Document:

Settlement Agreement, dated January 27, 2011

 EXHIBIT 10.4 
 SETTLEMENT AGREEMENT 
 THIS SETTLEMENT AGREEMENT (the
“Agreement”) is dated as of the 27th day of January, 2011 
 AMONG: 

ANGIOTECH PHARMACEUTICALS, INC., ANGIOTECH PHARMACEUTICALS (US), INC., QUILL MEDICAL, INC. 

(collectively, the “Angiotech Parties”) 
 and 
 THE ENTITIES LISTED ON SCHEDULE “A” HERETO 

(collectively, the “Angiotech Guarantors”) 
 and 
 QSR HOLDINGS, INC., for itself and in its capacity as Stockholder
Representative on behalf of the Company Holders 
 (“QSR”) 

and 
 DR.
GREGORY RUFF 
 (“Ruff”) 
 and 
 MATTHEW MEGARO 

(“Megaro”, and collectively with the Angiotech Parties, the Angiotech Guarantors, QSR and Ruff, the
“Parties”). 
 WHEREAS Quill Medical, Inc. entered into an Agreement and Plan of Merger with Quaich
Acquisition, Inc., Angiotech Pharmaceuticals, Inc. and Angiotech Pharmaceuticals (US), Inc., dated as of May 25, 2006 (the “Merger Agreement”), which provided for, among other things, contingent future payments and certain
obligations owed by one of more of the Angiotech Parties to the “Company Holders” (as defined in the Merger Agreement and including, but not limited to, those parties listed on Schedule “B” hereto); 

AND WHEREAS, pursuant to a Stockholder Representative Agreement that became effective upon consummation of the transactions
contemplated in the Merger Agreement, the 

  
 - 1 -

 
Company Holders appointed QSR as representative, attorney-in-fact and agent for and on behalf of, with authority to bind, each Company Holder with respect to matters pertaining to the Merger
Agreement and the contingent consideration to be received by the Company Holders under the Merger Agreement (the “Stockholder Representative”); 
 AND WHEREAS Megaro is the sole shareholder of QSR; 
 AND WHEREAS the
payments and obligations contingently owed by one or more of the Angiotech Parties to the Company Holders under the Merger Agreement included, among other things, the earnout payment pertaining to Earnout Year Five (as defined in the Merger
Agreement) as set out in Section 2.7(g)(v) of the Merger Agreement (the “Year Five Earnout Payment”), the “Wound Closure Milestone Payment” (as defined in the Merger Agreement) and the “Orthopedic
Milestone Payment” (as defined in the Merger Agreement); 
 AND WHEREAS the Merger Agreement provides that
certain other obligations may arise in certain contingent circumstances, including as a result of “Extraordinary Transactions” (as defined in the Merger Agreement) and/or “Bankruptcy Events” (as defined in the
Merger Agreement”); 
 AND WHEREAS the Year Five Earnout Payment, the Wound Closure Milestone Payment, the
Orthopedic Milestone Payment, any claims or obligations that may arise as a result of Extraordinary Transactions and/or Bankruptcy Events, and any and all other amounts, payments or other obligations to the Company Holders or QSR under the Merger
Agreement that are, or are claimed to be, presently outstanding or that may become due and outstanding after the date hereof are collectively referred to in this Agreement as the “QSR Merger Agreement Claims”; 

AND WHEREAS, on October 1, 2010, QSR commenced an action against the Angiotech Parties in the United States District Court
for the Middle District of North Carolina (the “QSR Litigation”), which action asserted certain claims against the Angiotech Parties in connection with the Merger Agreement (as more fully set forth in the Complaint in the QSR
Litigation, the “QSR Litigation Claims”); 
 AND WHEREAS, on October 1, 2010, QSR made a demand for
arbitration (the “QSR Arbitration”) pursuant to the American Arbitration Association Commercial Arbitration Rules in respect of the Angiotech Parties’ alleged failure to satisfy certain obligations under the Merger Agreement
(the “QSR Arbitration Claims” and collectively with the QSR Merger Agreement Claims and the QSR Litigation Claims, the “QSR Claims”); 
 AND WHEREAS the Parties are prepared to agree to the irrevocable dismissal with prejudice of the QSR Litigation and the QSR Arbitration and the full and final settlement of the QSR Claims and any
and all other claims relating to the Merger Agreement or otherwise that may be advanced by QSR, the Company Holders, Ruff, Megaro, any of QSR’s present or former shareholders, directors, officers or partners or any other persons or entities
having a present or former beneficial interest in QSR or QSR’s interests under the Merger Agreement (collectively with the QSR Claims, the “Settled Claims”); 

  
 - 2 -

 AND WHEREAS the Parties wish to enter into this Agreement in order to record and give
effect to such settlement; 
 AND WHEREAS QSR has the requisite authority as Stockholder Representative to enter into
this Agreement on behalf of each Company Holder in respect of the matters addressed in this Agreement and to bind each Company Holder to this Agreement as if each such Company Holder was a signatory hereto; 

AND WHEREAS the Angiotech Parties and the Angiotech Guarantors have entered into an agreement governing the terms of a proposed
recapitalization transaction (the “Recapitalization Transaction”) with certain holders of and/or investment advisors with investment discretion over approximately 74% of the aggregate principal amount of the 7.75% Senior
Subordinated Notes due April 1, 2014 issued by Angiotech Pharmaceuticals, Inc. (the “Consenting Noteholders”); 
 AND WHEREAS the terms of settlement set out herein have been acknowledged and consented to by the Consenting Noteholders; 
 NOW THEREFORE in consideration of the representations, covenants and mutual promises set forth in this Agreement and for other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the Parties hereby agree as follows: 
 1. Settlement Amount 

The Parties hereby agree and confirm that, in full and final settlement of the Settled Claims, the QSR Litigation and the QSR Arbitration, Angiotech
Pharmaceuticals (US), Inc. (“Angiotech US”) shall pay $6 million to QSR (the “Settlement Amount”), payable as follows: 
  

	 	(a)	$2.0 million shall be paid on the earlier of (i) 10 business days after the implementation of the Recapitalization Transaction (the “Implementation
Date”) and (ii) May 31, 2011; 

  

	 	(b)	the remaining $4.0 million shall be paid over a 24-month period in 24 monthly installments of $166,667, which monthly payments shall commence on the earlier of
(i) 30 days after the Implementation Date and (ii) July 31, 2011. 

 The Parties acknowledge that the payment of
the Settlement Amount is an unsecured obligation of Angiotech US. The Settlement Amount shall not bear interest. 
 2.
Prepayment of the Settlement Amount 
 All or any outstanding portion of the Settlement Amount may be prepaid to QSR at any time by
Angiotech US or at the direction of Angiotech US without bonus or penalty. If the full Settlement Amount is paid to QSR prior to or within 12 months following the Implementation Date, then Angiotech US shall be entitled to a discount of $300,000 on
the then outstanding portion of the Settlement Amount. 

  
 - 3 -

 3. Sale of the Quill Technology 

In the event that any of the Angiotech Parties or any of their controlled affiliates sells, transfers or disposes all or substantially all of the
technology and intellectual property relating to the “Quill” product that is presently owned by the Angiotech Parties and/or the Angiotech Guarantors (the “Quill Technology”) to any arm’s length third party, then any
outstanding portion of the Settlement Amount shall become immediately due and payable to QSR. For greater certainty, if the Settlement Amount is paid in full prior to or within 12 months following the Implementation Date as a result of such a sale,
transfer or disposition, the discount on the Settlement Amount provided for in Section 2 hereof shall not be applicable. For greater certainty, the repayment obligation in this Section 3 shall not apply to any sale, transfer or disposition
of the Quill Technology to an affiliate of an Angiotech Party or other non-arm’s length party in connection with the Recapitalization Transaction or otherwise. 
 4. Guarantees 
 The Angiotech Guarantors, for themselves and on behalf of their respective
successors and assigns, as guarantors and principal obligors, hereby jointly and severally guarantee to QSR the payment of the Settlement Amount by Angiotech US on the terms and conditions of this Agreement and the satisfaction of the Angiotech
Parties’ other obligations under this Agreement. The guarantees set out in this Section 4 are continuing guarantees and shall remain in full force and effect and shall not be satisfied or discharged until all obligations of the Angiotech
Parties that are guaranteed hereby have been discharged in full. The parties acknowledge that the obligations of the Angiotech Guarantors set out in this Section 4 are unsecured obligations of the Angiotech Guarantors. 

5. Waiver, Release and Discharge of Proceedings by QSR Releasors 
 QSR, Ruff and Megaro, for themselves, each of their respective heirs, successors, and assigns and on behalf of each of the Company Holders, each for his, her or itself and each of his, her or its
respective past or present parents, subsidiaries, affiliates, investment funds, heirs, predecessors, successors, assigns, and any of their respective past, present or future directors, officers, partners, members, managing directors, principals,
employees, agents, advisors, insurers or attorneys, and on behalf of QSR’s present and former shareholders, directors, officers, partners, predecessors, successors and assigns, and any other persons or entities having a present or former
beneficial interest in QSR and/or QSR’s or any Company Holder’s interests under the Merger Agreement (collectively, the “QSR Releasors”), hereby: 

 

	 	(a)	agree to irrevocably dismiss the QSR Litigation and the QSR Arbitration on a with-prejudice basis concurrently with the execution of this Agreement;

  

	 	(b)	 waive, release and surrender the Settled Claims and any and all present or future demands, claims, actions or causes of action, suits and proceedings,
and any and all debts, entitlements, sums of money, duties, dues, accounts, bonds, trust claims, counterclaims, covenants, damages, contracts, indemnities, guarantees, claims for contribution, expenses, demands, losses, deprivation, costs (legal and
otherwise), interest, judgments and liabilities, executions, liens and other recoveries on account of any 

  
 - 4 -

	 	 
indebtedness, liability, obligation, demand or cause of action of whatever nature that the QSR Releasors or any one of them may be entitled to assert, whether known or unknown, matured or
unmatured, direct, indirect or derivative, foreseen or unforeseen, existing or hereafter arising, based in whole or in part on any act or omission, transaction, dealing or other occurrence existing or taking place on or prior to the date of this
Agreement, whether in law or in equity, whether implied or expressed, by reason of, in connection with or arising out of or relating to the Merger Agreement, the Settled Claims, the QSR Litigation and/or the QSR Arbitration, against any of the
Angiotech Parties, the Angiotech Guarantors, or any of such parties’ affiliates or related entities and/or any of such parties’ present, former or future shareholders, directors, officers, partners, representatives, agents or creditors
(including any of such parties’ respective successors, assigns or estates and such estates as hereafter reorganized under applicable law) (collectively, the “Angiotech Released Parties”), provided, that nothing in this
Section 5(b) releases the Angiotech Parties or the Angiotech Guarantors from their respective obligations under this Agreement; 

  

	 	(c)	undertake, covenant and agree not to make any claim or take or participate in any proceedings (including, without limitation, any action, cross-claim, counterclaim,
third party action or application) to pursue or enforce any of the Settled Claims or any other claim in connection with the matters referred to in Section 5(b) hereof, either alone or with any other person, against any other person who would as
a result of such claim or proceeding have a claim for contribution or indemnity from any of the Angiotech Released Parties; and 

  

	 	(d)	undertake, covenant and agree (i) to not object to, delay, impede or take any other action to interfere with the acceptance or implementation of the
Recapitalization Transaction; and (ii) to not, without the prior written consent of the Angiotech Parties and the Consenting Noteholders, propose, file, support or vote in favour of any alternative exchange offer, restructuring, workout or plan
of compromise or arrangement or reorganization of or for the Angiotech Parties or the Angiotech Guarantors; and 

  

	 	(e)	undertake, covenant and agree to take any and all reasonable steps to support the implementation of the Recapitalization Transaction, including, without limitation, if
solicited, voting in favour of a plan embodying the terms of the Recapitalization Transaction. 

 6. Waiver and
Release by Angiotech Releasors 
 Subject only to the irrevocable dismissal of the QSR Litigation and the QSR Arbitration on a
with-prejudice basis as contemplated in Section 5(a) hereof, the Angiotech Parties and the Angiotech Guarantors, for themselves and on behalf of their respective past, present and former shareholders, directors, officers, partners, members,
managing directors, principals, employees, agents, advisors, insurers, attorneys, parents, subsidiaries, affiliates, investment funds, heirs, predecessors, successors, or assigns, and on behalf of any other persons or entities having a present or
former beneficial interest in the Angiotech Parties or their interests under the Merger Agreement (the “Angiotech Releasors”), hereby: 

  
 - 5 -

	 	(a)	waive, release and surrender any and all present or future demands, claims, actions or causes of action, suits and proceedings, and any and all debts, entitlements,
sums of money, duties, dues, accounts, bonds, trust claims, counterclaims, covenants, damages, contracts, indemnities, guarantees, claims for contribution, expenses, demands, losses, deprivation, costs (legal and otherwise), interest, judgments and
liabilities, executions, liens and other recoveries on account of any indebtedness, liability, obligation, demand or cause of action of whatever nature that the Angiotech Releasors or any one of them may be entitled to assert, whether known or
unknown, matured or unmatured, direct, indirect or derivative, foreseen or unforeseen, existing or hereafter arising, based in whole or in part on any act or omission, transaction, dealing or other occurrence existing or taking place on or prior to
the date of this Agreement, whether in law or in equity, whether implied or expressed, by reason of, in connection with or arising out of or relating to the Merger Agreement or QSR’s indemnification obligations relating to any litigation
between the Angiotech Parties and Covidien PLC, against any of QSR, the Company Holders, Ruff, Megaro, any of such parties’ affiliates or related parties and/or any of such parties’ present, former or future shareholders, directors,
officers, partners, representatives, agents or creditors (including any of such parties’ respective successors, assigns or estates) (collectively, the “QSR Released Parties”), provided, that nothing in this Section 6(a)
releases QSR, Ruff, Megaro or the Company Holders from their respective obligations under this Agreement; and 

  

	 	(b)	undertake, covenant and agree not to make any claim or take or participate in any proceedings (including, without limitation, any action, cross-claim, counterclaim,
third party action or application) to pursue or enforce any claims in connection with the matters referred to in Section 6(a) hereof, either alone or with any other person, against any other person who would as a result of such claim or
proceeding have a claim for contribution or indemnity from any of the QSR Released Parties. 

 7. No Admission

 Each of the Parties agree that the payment and delivery of the Settlement Amount, the settlement of the Settled Claims, the releases
effected pursuant to Sections 5 and 6 hereof and/or the execution of this Settlement Agreement by the Parties hereto, are not, and shall not be construed as, an admission of liability on the part of any of the Parties hereto or any of the Angiotech
Released Parties or QSR Released Parties. 
 8. Representations and Warranties 

Each of the Parties represents and warrants as follows, and acknowledges and confirms that each of the Parties is relying upon such representations and
warranties in connection with entering into this Agreement: 
  

	 	(a)	such Party has full capacity and power to enter into this Agreement; 

  

	 	(b)	such Party has sufficient knowledge and experience to evaluate and understand the terms and conditions of this Agreement; 

  
 - 6 -

	 	(c)	such Party has conducted its own analysis and made its own decision to enter into this Agreement and has obtained such independent professional advice, including legal
advice, in this regard as it deems appropriate; 

  

	 	(d)	such Party has entered into this Agreement voluntarily and without reliance upon any inducement, agreement, condition, representation or warranty from any person
whatsoever, save and except as expressly set out herein; 

  

	 	(e)	the execution and delivery of this Agreement by such Party has been authorized by all necessary action; and 

 

	 	(f)	this Agreement constitutes a valid and binding obligation of such Party, enforceable against such Party in accordance with the terms hereof. 

Each of QSR, Ruff and Megaro represent and warrant to the Angiotech Parties and the Angiotech Guarantors that (i) QSR has the authority and power as
Stockholder Representative to act on behalf of and bind each Company Holder with respect to the all matters addressed in this Agreement, (ii) all releases, waivers, obligations and other matters agreed to by QSR pursuant to this Agreement bind
the Company Holders in the same manner and to the same extent as if the Company Holders had personally executed this Agreement, and (iii) after giving effect to this Agreement, QSR, the Company Holders, Ruff and Megaro will have no claims of
any nature or kind whatsoever as against any of the Angiotech Released Parties with respect to the Settled Claims, the QSR Litigation, the QSR Arbitration or any other matters released pursuant to Section 5(b) hereof. 

Each of the Angiotech Parties and the Angiotech Guarantors represents and warrants that after giving effect to this Agreement, the Angiotech Parties and
the Angiotech Guarantors will have no claims of any nature or kind whatsoever as against any of the QSR Released Parties with respect to the claims released pursuant to Section 6(a) hereof. 

9. Performance of Obligations 
 The Angiotech Parties and the Angiotech Guarantors hereby undertake and agree that (i) they shall not repudiate, resiliate or disclaim this Agreement in any insolvency proceeding in the United
States of America or Canada, including, without limitation, any proceeding under the Companies’ Creditors Arrangement Act (Canada) and (ii) the Angiotech Parties and the Angiotech Guarantors shall perform their
obligations under this Agreement despite any restructuring, recapitalization or reorganization of the Angiotech Parties and the Angiotech Guarantors, including pursuant to the Recapitalization Transaction. The Consenting Noteholders acknowledge and
consent to the terms of this Section 9. 
 10. Benefit of Agreement 

This Agreement shall be binding upon and enure to the benefit of the Parties and their respective successors and assigns. The Parties acknowledge and
agree that this Agreement is made, inter alia, for the benefit of, and may be relied upon and enforced by, the Angiotech Released Parties and the QSR Released Parties notwithstanding that not all of such parties are signatories hereto.

  
 - 7 -

 
For greater certainty, all releases, waivers, obligations and other matters agreed to by QSR pursuant to this Agreement shall be binding on the Company Holders in the same manner and to the same
extent as if the Company Holders had personally executed this Agreement. 
 11. Severability 

If any provision of this Agreement is held to be invalid, illegal or unenforceable, the validity, legality or enforceability of the remainder of this
Agreement shall not in any way be affected or impaired thereby and this Agreement shall be carried out as nearly as possible in accordance with its original terms and conditions. 

12. Currency 
 Unless
otherwise expressly stated otherwise, all dollar amounts in this Agreement refer to United State dollars. 
 13. Counterparts

 This Agreement may be executed in any number of counterparts (by e-mail, facsimile or otherwise), each of which shall be deemed to be an
original and all of which, when taken together, shall be deemed to constitute one and the same instrument. It shall not be necessary in making proof of this Agreement to produce more than one counterpart. 

14. Disclosure 
 The
Parties acknowledge and agree that the Angiotech Parties may publicly disclose this Agreement following its execution by the Parties, whether as part of the Angiotech Parties’ ongoing public disclosure under applicable securities laws and/or
regulations, as part of any materials filed in court proceedings to implement the Recapitalization Transaction or otherwise, provided that the names of the Company Holders listed on Schedule “B” hereto shall be redacted from any such
public disclosure. The Agreement and all of the terms herein (including the quantum of the Settlement Amount) shall remain in strict confidence until such time as the Angiotech Parties have publicly disclosed this Agreement. For greater certainty,
the Parties agree that the terms of this Agreement may be provided to the Company Holders, provided that, the Company Holders shall be required to maintain this Agreement and all of the terms herein (including the quantum of the Settlement Amount)
in strict confidence until such time as the Angiotech Parties have publicly disclosed this Agreement. 
 15. Entire Agreement

 This Agreement constitutes the entire agreement between the Parties with respect to the matters herein and supersedes all prior
agreements, understandings, negotiations and discussions relating to the subject matter hereof. There are no other covenants, agreements, representations, warranties, conditions, whether direct or collateral, express or implied, that form part of or
affect this Agreement except as otherwise provided herein. The execution of this Agreement has not been induced by, nor do any of the parties rely upon or regard as material, any representations, promises, agreements or statements not incorporated
into this Agreement. This Agreement shall not be amended, added to or qualified except by written agreement signed by each of the Parties. 

  
 - 8 -

 16. Further Assurances 
 The Parties shall do all such things, acting reasonably, and provide all such reasonable assurances as may be required to consummate the transactions contemplated by this Agreement, and each party to this
Agreement shall do, execute and deliver, or shall cause to be executed and delivered, all such further acts, documents, instruments and things as may be reasonably necessary or desirable to effect the purpose of this Agreement and carry out its
provisions. 
 17. Attornment 
 Each of the Parties agree that any action or proceeding arising out of or relating to this Agreement may be instituted in any of the courts of the State of or federal district of Delaware, the State of or
any federal district of New York, and Province of British Columbia, waive any objection that it may have now or hereafter to the venue of any such action or proceeding, irrevocably submit to the exclusive jurisdiction of the said courts in any such
action or proceeding, agree to be bound by any judgment of the said courts and agree not to seek and hereby waive any review of the merits of any such judgment by the courts of any other jurisdiction. 

18. Governing Law 
 This
Agreement shall be governed by and construed in accordance with the laws of the State of New York. 
 [The remainder of
this page is intentionally left blank.] 

  
 - 9 -

 IN WITNESS WHEREOF the parties have duly executed this Agreement as of the date
first above written. 
  

			
	ANGIOTECH PHARMACEUTICALS, INC.,
	ANGIOTECH PHARMACEUTICALS (US),
	INC., QUILL MEDICAL, INC.
		
	Per:	 	/s/ K. Thomas Bailey
	Name:  K. Thomas Bailey
	Title:  Authorized Signatory
	
	I have authority to bind the above named corporations.
	
	AFMEDICA, INC.;
	 AMERICAN MEDICAL INSTRUMENTS
 HOLDINGS, INC.;

	ANGIOTECH AMERICA, INC.;
	ANGIOTECH BIOCOATINGS CORP.;
	ANGIOTECH DELAWARE, INC.;
	ANGIOTECH FLORIDA HOLDINGS, INC.;
	B.G. SULZLE, INC.;
	MANAN MEDICAL PRODUCTS, INC.;
	MEDICAL DEVICE TECHNOLOGIES, INC.;
	NEUCOLL, INC.;
	SURGICAL SPECIALTIES CORPORATION;
	SURGICAL SPECIALTIES PUERTO RICO,
	INC.; and
	SURGICAL SPECIALTIES UK HOLDINGS
	LIMITED
		
	Per:	 	/s/ K. Thomas Bailey
	Name:  K. Thomas Bailey
	Title:  Authorized Signatory
	
	I have authority to bind the above named corporations.
	
	ANGIOTECH INTERNATIONAL
	HOLDINGS CORP.; and 0741693 B.C. LTD.
		
	Per:	 	/s/ Jay Dent
	Name: Jay Dent
	Title: Authorized Signatory
	
	I have authority to bind the above named corporations.

  
 - 10 -

 
			
	QSR HOLDINGS, INC.
	Per:	 	/s/ Matthew Megaro
	Name: Matthew Megaro
	Title: Authorized Signatory
	
	I/we have authority to bind the corporation.
	
	DR. GREGORY RUFF
	
	/s/ Gregory Ruff MD
	
	MATTHEW MEGARO
	
	/s/ Matthew Megaro

  
 - 11 -

 THIS AGREEMENT IS ACKNOWLEDGED AND CONSENTED TO by the Consenting Noteholders.

  

			
	GOODMANS LLP, in its capacity as counsel to the Consenting Noteholders, for and on behalf of the Consenting Noteholders.
		
	Per:	 	/s/ Celia Rhea
	Name: Celia Rhea
	Title: Partner
	
	I/we have authority to bind the above named parties

  
 - 12 -Form of Senior Debt Indenture

 EXHIBIT 4.5 

 
  

 
 FORM OF INDENTURE TO BE ENTERED
INTO BETWEEN 
 THE COMPANY AND THE TRUSTEE 
 RAINMAKER SYSTEMS, INC. 
  

 
 INDENTURE

 Dated as of [            ], 200[    ]

  
  

[                    ] 

Trustee 
 SENIOR
DEBT SECURITIES 
  
  

 

 TABLE OF CONTENTS 

 

							
	 	  	 	  	Page	 
	 Article I.     DEFINITIONS AND INCORPORATION BY REFERENCE Section 1
	  	 	1	  
			
	 Section 1.1
	  	Definitions	  	 	1	  
			
	 Section 1.2
	  	Other Definitions	  	 	5	  
			
	 Section 1.3
	  	Incorporation by Reference of Trust Indenture Act	  	 	5	  
			
	 Section 1.4
	  	Rules of Construction	  	 	6	  
		
	 Article II.     THE SECURITIES
	  	 	6	  
			
	 Section 2.1
	  	Issuable in Series	  	 	6	  
			
	 Section 2.2
	  	Establishment of Terms of Series of Securities	  	 	7	  
			
	 Section 2.3
	  	Execution and Authentication	  	 	9	  
			
	 Section 2.4
	  	Registrar and Paying Agent	  	 	10	  
			
	 Section 2.5
	  	Paying Agent to Hold Money in Trust	  	 	11	  
			
	 Section 2.6
	  	Securityholder Lists	  	 	11	  
			
	 Section 2.7
	  	Transfer and Exchange	  	 	11	  
			
	 Section 2.8
	  	Mutilated, Destroyed, Lost and Stolen Securities	  	 	12	  
			
	 Section 2.9
	  	Outstanding Securities	  	 	12	  
			
	 Section 2.10
	  	Treasury Securities	  	 	13	  
			
	 Section 2.11
	  	Temporary Securities	  	 	13	  
			
	 Section 2.12
	  	Cancellation	  	 	13	  
			
	 Section 2.13
	  	Defaulted Interest	  	 	13	  
			
	 Section 2.14
	  	Global Securities	  	 	14	  
			
	 Section 2.15    
	  	CUSIP Numbers	  	 	15	  
		
	 Article III.     REDEMPTION
	  	 	15	  
			
	 Section 3.1
	  	Notice to Trustee	  	 	15	  
			
	 Section 3.2
	  	Selection of Securities to be Redeemed	  	 	15	  
			
	 Section 3.3
	  	Notice of Redemption	  	 	16	  
			
	 Section 3.4
	  	Effect of Notice of Redemption	  	 	16	  
			
	 Section 3.5
	  	Deposit of Redemption Price	  	 	17	  
			
	 Section 3.6
	  	Securities Redeemed in Part	  	 	17	  
		
	 Article IV.     COVENANTS
	  	 	17	  
			
	 Section 4.1
	  	Payment of Principal and Interest	  	 	17	  

  
 -i-

 TABLE OF CONTENTS 

(continued) 
  

							
	 	  	 	  	Page	 
	 Section 4.2
	  	SEC Reports	  	 	17	  
			
	 Section 4.3
	  	Compliance Certificate	  	 	17	  
			
	 Section 4.4
	  	Stay, Extension and Usury Laws	  	 	18	  
			
	 Section 4.5
	  	Maintenance of Office or Agency	  	 	18	  
			
	 Section 4.6
	  	Corporate Existence	  	 	18	  
			
	 Section 4.7
	  	Taxes	  	 	19	  
		
	 Article V.     SUCCESSORS
	  	 	19	  
			
	 Section 5.1
	  	Successor Corporation Substituted	  	 	19	  
		
	 Article VI.     DEFAULTS AND REMEDIES
	  	 	19	  
			
	 Section 6.1
	  	Events of Default	  	 	19	  
			
	 Section 6.2
	  	Acceleration of Maturity; Rescission and Annulment	  	 	20	  
			
	 Section 6.3
	  	Collection of Indebtedness and Suits for Enforcement by Trustee	  	 	21	  
			
	 Section 6.4
	  	Trustee May File Proofs of Claim	  	 	22	  
			
	 Section 6.5
	  	Trustee May Enforce Claims Without Possession of Securities	  	 	23	  
			
	 Section 6.6
	  	Application of Money Collected	  	 	23	  
			
	 Section 6.7
	  	Limitation on Suits	  	 	23	  
			
	 Section 6.8
	  	Unconditional Right of Holders to Receive Principal and Interest	  	 	24	  
			
	 Section 6.9
	  	Restoration of Rights and Remedies	  	 	24	  
			
	 Section 6.10
	  	Rights and Remedies Cumulative	  	 	24	  
			
	 Section 6.11
	  	Delay or Omission Not Waiver	  	 	25	  
			
	 Section 6.12
	  	Control by Holders	  	 	25	  
			
	 Section 6.13
	  	Waiver of Past Defaults	  	 	25	  
			
	 Section 6.14    
	  	Undertaking for Costs	  	 	25	  
		
	 Article VII.     TRUSTEE
	  	 	26	  
			
	 Section 7.1
	  	Duties of Trustee	  	 	26	  
			
	 Section 7.2
	  	Rights of Trustee	  	 	27	  
			
	 Section 7.3
	  	Individual Rights of Trustee	  	 	28	  
			
	 Section 7.4
	  	Trustee’s Disclaimer	  	 	28	  
			
	 Section 7.5
	  	Notice of Defaults	  	 	28	  

  
 -ii-

 TABLE OF CONTENTS 

(continued) 
  

							
	 	  	 	  	Page	 
	 Section 7.6
	  	Reports by Trustee to Holders	  	 	29	  
			
	 Section 7.7
	  	Compensation and Indemnity	  	 	29	  
			
	 Section 7.8
	  	Replacement of Trustee	  	 	30	  
			
	 Section 7.9
	  	Successor Trustee by Merger, etc	  	 	31	  
			
	 Section 7.10
	  	Eligibility; Disqualification	  	 	31	  
			
	 Section 7.11    
	  	Preferential Collection of Claims Against Company	  	 	31	  
		
	Article VIII.     SATISFACTION AND DISCHARGE; DEFEASANCE	  	 	31	  
			
	 Section 8.1
	  	Satisfaction and Discharge of Indenture	  	 	31	  
			
	 Section 8.2
	  	Application of Trust Funds; Indemnification	  	 	32	  
			
	 Section 8.3
	  	Legal Defeasance of Securities of any Series	  	 	33	  
			
	 Section 8.4
	  	Covenant Defeasance	  	 	34	  
			
	 Section 8.5
	  	Repayment to Company	  	 	36	  
			
	 Section 8.6
	  	Reinstatement	  	 	36	  
		
	Article IX.     AMENDMENTS AND WAIVERS	  	 	36	  
			
	 Section 9.1
	  	Without Consent of Holders	  	 	36	  
			
	 Section 9.2
	  	With Consent of Holders	  	 	37	  
			
	 Section 9.3
	  	Limitations	  	 	37	  
			
	 Section 9.4
	  	Compliance with Trust Indenture Act	  	 	38	  
			
	 Section 9.5
	  	Revocation and Effect of Consents	  	 	38	  
			
	 Section 9.6
	  	Notation on or Exchange of Securities	  	 	39	  
			
	 Section 9.7
	  	Trustee Protected	  	 	39	  
			
	 Section 9.8
	  	Payment for Consent	  	 	39	  
		
	Article X.     MISCELLANEOUS	  	 	39	  
			
	 Section 10.1
	  	Trust Indenture Act Controls	  	 	39	  
			
	 Section 10.2
	  	Notices	  	 	40	  
			
	 Section 10.3
	  	Communication by Holders with Other Holders	  	 	40	  
			
	 Section 10.4
	  	Certificate and Opinion as to Conditions Precedent	  	 	41	  
			
	 Section 10.5
	  	Statements Required in Certificate or Opinion	  	 	41	  
			
	 Section 10.6
	  	Rules by Trustee and Agents	  	 	41	  
			
	 Section 10.7
	  	Legal Holidays	  	 	41	  

  
 -iii-

 TABLE OF CONTENTS 

(continued) 
  

							
	 	  	 	  	Page	 
	 Section 10.8
	  	No Recourse Against Others	  	 	41	  
			
	 Section 10.9
	  	Counterparts	  	 	42	  
			
	 Section 10.10    
	  	Governing Laws	  	 	42	  
			
	 Section 10.11
	  	No Adverse Interpretation of Other Agreements	  	 	42	  
			
	 Section 10.12
	  	Successors	  	 	42	  
			
	 Section 10.13
	  	Severability	  	 	42	  
			
	 Section 10.14
	  	Table of Contents, Headings, Etc	  	 	42	  
			
	 Section 10.15
	  	Securities in a Foreign Currency or in ECU	  	 	42	  
			
	 Section 10.16
	  	Judgment Currency	  	 	43	  
		
	 Article XI.     SINKING FUNDS
	  	 	44	  
			
	 Section 11.1
	  	Applicability of Article	  	 	44	  
			
	 Section 11.2
	  	Satisfaction of Sinking Fund Payments with Securities	  	 	44	  
			
	 Section 11.3
	  	Redemption of Securities for Sinking Fund	  	 	45	  

  
 -iv-

 RAINMAKER SYSTEMS, INC. 

Reconciliation and tie between TIA and Indenture 
  

					
	Section 310(a)(1)	 		  	7.1
	(a)(2)	 		  	7.1
	(a)(3)	 		  	Not Applicable
	(a)(4)	 		  	Not Applicable
	(a)(5)	 		  	7.1
	(b)	 		  	7.1
	Section 311(a)	 		  	7.11
	(b)	 		  	7.11
	(c)	 		  	Not Applicable
	Section 312(a)	 		  	2.6
	(b)	 		  	10.3
	(c)	 		  	10.3
	Section 313(a)	 		  	7.6
	(b)(1)	 		  	7.6
	(b)(2)	 		  	7.6
	(c)(1)	 		  	7.6
	(d)	 		  	7.6
	Section 314(a)	 		  	4.2, 10.5
	(b)	 		  	Not Applicable
	(c)(1)	 		  	10.4
	(c)(2)	 		  	10.4
	(c)(3)	 		  	Not Applicable
	(d)	 		  	Not Applicable
	(e)	 		  	10.5
	(f)	 		  	Not Applicable
	Section 315(a)	 		  	7.1
	(b)	 		  	7.5
	(c)	 		  	7.1
	(d)	 		  	7.1
	(e)	 		  	6.14
	Section 316(a)	 		  	2.1
	a)(1)(A)	 		  	6.12
	a)(1)(B)	 		  	6.13
	b)	 		  	6.8
	Section 317(a)(1)	 		  	6.3
	(a)(2)	 		  	6.4
	(b)	 		  	2.5
	Section 318(a)	 		  	10.1

  

Note: This reconciliation and tie shall not, for any purpose, be deemed to be part of the Indenture. 

  
 -v-

 Indenture dated as of
[            ], 200[            ], between Rainmaker Systems, Inc., a Delaware corporation (the “COMPANY”), and
[            ], a [            ] banking association (the “TRUSTEE”). 

Each party agrees as follows for the benefit of the other party and for the equal and ratable benefit of the Holders of
the Securities issued from time to time under this Indenture. 
 ARTICLE I. 

DEFINITIONS AND INCORPORATION BY REFERENCE SECTION 1. 
 Section 1.1 Definitions. 
 “ADDITIONAL
AMOUNTS” means any additional amounts which are required hereby or by any Security, under circumstances specified herein or therein, to be paid by the Company in respect of certain taxes imposed on Holders specified therein and which are owing
to such Holders. 
 “AFFILIATE” of any specified Person means any other Person directly or indirectly
controlling or controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, “control” (including, with correlative meanings, the terms “controlled by” and “under
common control with”), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting
securities or by agreement or otherwise. 
 “AGENT” means any Registrar, Paying Agent, Service Agent or
authenticating agent. 
 “AUTHORIZED NEWSPAPER” means a newspaper in an official language of the
country of publication customarily published at least once a day for at least five days in each calendar week and of general circulation in the place in connection with which the term is used. If it shall be impractical to make any publication of
any notice required hereby in an Authorized Newspaper, any publication or other notice in lieu thereof that is made or given by the Trustee shall constitute a sufficient publication of such notice. 

“BEARER” means anyone in possession from time to time of a Bearer Security. 

“BEARER SECURITY” means any Security, including any interest coupon appertaining thereto, that does not provide
for the identification of the Holder thereof. 
 “BOARD OF DIRECTORS” means the Board of Directors of
the Company or any duly authorized committee thereof. 
 “BOARD RESOLUTION” means a copy of a
resolution certified by the Secretary or an Assistant Secretary of the Company to have been adopted by the Board of Directors or pursuant to authorization by the Board of Directors and to be in full force and effect on the date of the certificate,
and delivered to the Trustee. 

  
 -1-

 “BUSINESS DAY” means, unless otherwise provided by Board
Resolution, Officers’ Certificate or supplemental indenture hereto for a particular Series, any day except a Saturday, Sunday or a legal holiday in The City of New York or the City of San Francisco on which banking institutions are authorized
or required by law, regulation or executive order to close. 
 “COMPANY” means the party named as such
above until a successor replaces it and thereafter means the successor. 
 “COMPANY ORDER” means a
written order signed in the name of the Company by two Officers, one of whom must be the Company’s chief executive officer, chief financial officer or principal accounting officer. 

“COMPANY REQUEST” means a written request signed in the name of the Company by its Chairman of the Board, its
Chief Executive Officer, its President or a Vice President, and by its Treasurer, an Assistant Treasurer, its Secretary or an Assistant Secretary, and delivered to the Trustee. 

“CORPORATE TRUST OFFICE” means the office of the Trustee at which at any particular time its corporate trust
business shall be principally administered. 
 “DEBT” of any Person as of any date means, without
duplication, all indebtedness of such Person in respect of borrowed money, including all interest, fees and expenses owed in respect thereto (whether or not the recourse of the lender is to the whole of the assets of such Person or only to a portion
thereof), or evidenced by bonds, notes, debentures or similar instruments. 
 “DEFAULT” means any event
which is, or after notice or passage of time would be, an Event of Default. 
 “DEPOSITORY” means, with
respect to the Securities of any Series issuable or issued in whole or in part in the form of one or more Global Securities, the Person designated as Depository for such Series by the Company, which Depository shall be a clearing agency registered
under the Exchange Act; and if at any time there is more than one such Person, “Depository” as used with respect to the Securities of any Series shall mean the Depository with respect to the Securities of such Series. 

“DISCOUNT SECURITY” means a Security which is issued at a price which is less than such Security’s stated
principal amount at maturity. 
 “DOLLARS” means the currency of The United States of America.

 “ECU” means the European Currency Unit as determined by the Commission of the European Union.

 “EXCHANGE ACT” means the Securities Exchange Act of 1934, as amended. 

  
 -2-

 “FOREIGN CURRENCY” means any currency or currency unit issued by a
government other than the government of The United States of America. 
 “FOREIGN GOVERNMENT
OBLIGATIONS” means with respect to Securities of any Series that are denominated in a Foreign Currency, (i) direct obligations of the government that issued or caused to be issued such currency for the payment of which obligations its full
faith and credit is pledged or (ii) obligations of a Person controlled or supervised by or acting as an agency or instrumentality of such government the timely payment of which is unconditionally guaranteed as a full faith and credit obligation
by such government, which, in either case under clause (i) or (ii), are not callable or redeemable at the option of the issuer thereof. 
 “GLOBAL SECURITY” or “GLOBAL SECURITIES” means a Security or Securities, as the case may be, in the form established pursuant to Section 2.14 evidencing all or part of a Series of
Securities, issued to the Depository for such Series or its nominee, and registered in the name of such Depository or nominee. 
 “HOLDER” or “SECURITYHOLDER” means a Person in whose name a Security is registered or the holder of a Bearer Security. 

“INDENTURE” means this Indenture as amended from time to time and shall include the form and terms of particular
Series of Securities established as contemplated hereunder. 
 “MATURITY” means, when used with respect
to any Security or installment of principal thereof, the date on which the principal of such Security or such installment of principal becomes due and payable as therein or herein provided, whether at the Stated Maturity or by declaration of
acceleration, call for redemption, notice of option to elect repayment or otherwise. 
 “OFFICER” means
the Chairman of the Board, the Chief Executive Officer, the President, any Vice-President, the Treasurer, the Secretary, any Assistant Treasurer or any Assistant Secretary of the Company. 

“OFFICERS’ CERTIFICATE” means a certificate signed by two Officers, one of whom must be the Company’s
principal executive officer, principal financial officer or principal accounting officer. 
 “OPINION OF
COUNSEL” means a written opinion of legal counsel who is acceptable to the Trustee. The counsel may be an employee of or counsel to the Company. 
 “PERSON” means any individual, corporation, partnership, joint venture, association, limited liability company, joint-stock company, trust, unincorporated organization or government or any
agency or political subdivision thereof. 
 “PRINCIPAL” of a Security means the principal of the
Security plus, when appropriate, the premium, if any, on, and any Additional Amounts in respect of, the Security. 

  
 -3-

 “RESPONSIBLE OFFICER” means any officer of the Trustee in its
Corporate Trust Office and also means, with respect to a particular corporate trust matter, any other officer to whom any corporate trust matter is referred because of his or her knowledge of and familiarity with a particular subject. 

“SEC” means the Securities and Exchange Commission. 

“SECURITIES” means the debentures, notes or other debt instruments of the Company of any Series authenticated
and delivered under this Indenture. 
 “SERIES” or “SERIES OF SECURITIES” means each series
of debentures, notes or other Debt instruments of the Company created pursuant to Sections 2.1 and 2.2 hereof. 

“SIGNIFICANT SUBSIDIARY” means (i) any direct or indirect Subsidiary of the Company that would be a
“significant subsidiary” as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act of 1933, as amended, as such regulation is in effect on the date hereof, or (ii) any group of direct or indirect
Subsidiaries of the Company that, taken together as a group, would be a “significant subsidiary” as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act of 1933, as amended, as such regulation is in
effect on the date hereof. 
 “STATED MATURITY” when used with respect to any Security or any
installment of principal thereof or interest thereon, means the date specified in such Security as the fixed date on which the principal of such Security or such installment of principal or interest is due and payable. 

“SUBSIDIARY” of any specified Person means any corporation of which at least a majority of the outstanding stock
having by the terms thereof ordinary voting power for the election of directors of such corporation (irrespective of whether or not at the time stock of any other class or classes of such corporation shall have or might have voting power by reason
of the happening of any contingency) is at the time directly or indirectly owned by such Person, or by one or more other Subsidiaries, or by such Person and one or more other Subsidiaries. 

“TIA” means the Trust Indenture Act of 1939 (15 U.S. Code Sections 77aaa-77bbbb) as in effect on the date of
this Indenture; provided, however, that in the event the Trust Indenture Act of 1939 is amended after such date, “TIA” means, to the extent required by any such amendment, the Trust Indenture Act as so amended. 

“TRUSTEE” means the Person named as the “Trustee” in the first paragraph of this instrument until a
successor Trustee shall have become such pursuant to the applicable provisions of this Indenture, and thereafter “Trustee” shall mean or include each Person who is then a Trustee hereunder, and if at any time there is more than one such
Person, “Trustee” as used with respect to the Securities of any Series shall mean the Trustee with respect to Securities of that Series. 
 “U.S. GOVERNMENT OBLIGATIONS” means securities which are (i) direct obligations of The United States of America for the payment of which its full faith and credit is pledged or
(ii) obligations of a Person controlled or supervised by and acting as an agency or 

  
 -4-

 
instrumentality of The United States of America the payment of which is unconditionally guaranteed as a full faith and credit obligation by The United States of America, and which in the case of
(i) and (ii) are not callable or redeemable at the option of the issuer thereof, and shall also include a depository receipt issued by a bank or trust company as custodian with respect to any such U.S. Government Obligation or a specific
payment of interest on or principal of any such U.S. Government Obligation held by such custodian for the account of the holder of a depository receipt; provided that (except as required by law) such custodian is not authorized to make any deduction
from the amount payable to the holder of such depository receipt from any amount received by the custodian in respect of the U.S. Government Obligation evidenced by such depository receipt. 

Section 1.2 Other Definitions. 
  

			
	 TERM
	  	DEFINED
IN SECTION
	 Bankruptcy Law
	  	6.1
	 Custodian
	  	6.1
	 Event of Default
	  	6.1
	 Journal
	  	10.15
	 Judgment Currency
	  	10.16
	 Legal Holiday
	  	10.7
	 Mandatory Sinking Fund Payment
	  	11.1
	 Market Exchange Rate
	  	10.15
	 New York Banking Day
	  	10.16
	 Optional Sinking Fund Payment
	  	11.1
	 Paying Agent
	  	2.4
	 Registrar
	  	2.4
	 Required Currency
	  	10.16
	 Service Agent
	  	2.4

 Section 1.3 Incorporation by
Reference of Trust Indenture Act. 
 Whenever this Indenture refers to a provision of the TIA, the
provision is incorporated by reference in and made a part of this Indenture. The following TIA terms used in this Indenture have the following meanings: 
 “COMMISSION” means the SEC. 
 “INDENTURE
SECURITIES” means the Securities. 
 “INDENTURE SECURITY HOLDER” means a Securityholder.

 “INDENTURE TO BE QUALIFIED” means this Indenture. 

  
 -5-

 “INDENTURE TRUSTEE” or “INSTITUTIONAL TRUSTEE” means the
Trustee. 
 “OBLIGOR” on the indenture securities means the Company and any successor obligor upon the
Securities. 
 All other terms used in this Indenture that are defined by the TIA, defined by TIA reference to
another statute or defined by SEC rule under the TIA and not otherwise defined herein are used herein as so defined. 
 Section
1.4 Rules of Construction. 
 Unless the context otherwise requires: 

(a) a term has the meaning assigned to it; 

(b) an accounting term not otherwise defined has the meaning assigned to it in accordance with generally accepted
accounting principles; 
 (c) references to “GENERALLY ACCEPTED ACCOUNTING PRINCIPLES” shall mean
generally accepted accounting principles in effect as of the time when and for the period as to which such accounting principles are to be applied; 
 (d) “OR” is not exclusive; 
 (e) words in the singular
include the plural, and in the plural include the singular; and 
 (f) provisions apply to successive events and
transactions. 
 ARTICLE II. 
 THE SECURITIES 
 Section 2.1 Issuable in Series. 

The aggregate principal amount of Securities that may be authenticated and delivered under this Indenture is unlimited.
The Securities may be issued in one or more Series. All Securities of a Series shall be identical except as may be set forth in a Board Resolution, a supplemental indenture hereto or an Officers’ Certificate detailing the adoption of the terms
thereof pursuant to the authority granted under a Board Resolution. In the case of Securities of a Series to be issued from time to time, the Board Resolution, supplemental indenture hereto or Officers’ Certificate may provide for the method by
which specified terms (such as interest rate, maturity date, record date or date from which interest shall accrue) are to be determined. Securities may differ between Series in respect of any matters; provided that all Series of Securities shall be
equally and ratably entitled to the benefits of the Indenture. 

  
 -6-

 Section 2.2 Establishment of Terms of Series of Securities. 

At or prior to the issuance of any Securities within a Series, the following shall be established by a Board Resolution, a
supplemental indenture hereto or an Officers’ Certificate pursuant to authority granted under a Board Resolution: 
 2.2.1 the title of the Series (which shall distinguish the Securities of that particular Series from the Securities of any other Series); 

2.2.2 the price or prices (expressed as a percentage of the principal amount thereof) at which the Securities of the
Series will be issued; 
 2.2.3 any limit upon the aggregate principal amount of the Securities of the Series
which may be authenticated and delivered under this Indenture (except for Securities authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of the Series pursuant to Section 2.7, 2.8,
2.11, 3.6 or 9.6); 
 2.2.4 the Stated Maturity or Maturity on which the principal of the Securities of the
Series is payable or the method of determination thereof; 
 2.2.5 the rate or rates (which may be fixed or
variable) per annum or, if applicable, the method used to determine such rate or rates (including, but not limited to, any commodity, commodity index, stock exchange index or financial index) at which the Securities of the Series shall bear
interest, if any; 
 2.2.6 the date or dates from which such interest, if any, shall accrue, the date or dates on
which such interest, if any, shall commence and be payable and any regular record date for the interest payable on any interest payment date or the manner of determination of such date and the record date for the determination of holders to whom
interest is payable on such date; 
 2.2.7 the Persons who shall be entitled to receive interest on the Series of
Securities, if other than the record holder on the record date; 
 2.2.8 the place or places where the principal
of and interest, if any, on the Securities of the Series shall be payable, or the method of such payment, if by wire transfer, mail or other means; 
 2.2.9 the right, if any, to extend or defer the payment of interest on the Securities of the Series and the duration of such extension; 

2.2.10 if applicable, the period or periods within which the price or prices at which and the terms and conditions upon
which the Securities of the Series may be redeemed, in whole or in part, at the option of the Company; 
 2.2.11
the obligation, if any, of the Company to redeem or purchase the Securities of the Series pursuant to any sinking fund or analogous provisions or at the option of a Holder thereof and the period or periods within which, the price or prices at which
and the terms and conditions upon which Securities of the Series shall be redeemed or purchased, in whole or in part, pursuant to such obligation; 

  
 -7-

 2.2.12 the dates, if any, on which, and the price or prices at which, the
Securities of the Series will be repurchased by the Company at the option of the Holders thereof and other detailed terms and provisions of such repurchase obligations; 

2.2.13 if other than denominations of $1,000 and any integral multiple thereof, the denominations in which the Securities
of the Series shall be issuable; 
 2.2.14 the forms of the Securities of the Series in bearer or fully
registered form (and, if in fully registered form, whether the Securities will be issuable as Global Securities); 
 2.2.15 if other than the principal amount thereof, the portion of the principal amount of the Securities of the Series that shall be payable upon declaration of acceleration of the maturity thereof
pursuant to Section 6.2; 
 2.2.16 whether the Securities will be convertible into or exchangeable for
shares of common stock or other securities of the Company and, if so, the terms and conditions upon which such Securities will be convertible or exchangeable, including the conversion or exchange price and the conversion or exchange period;

 2.2.17 the currency of denomination of the Securities of the Series, which may be Dollars or any Foreign
Currency, including, but not limited to, the ECU, and if such currency of denomination is a composite currency other than the ECU, the agency or organization, if any, responsible for overseeing such composite currency; 

2.2.18 the designation of the currency, currencies or currency units in which payment of the principal of and interest, if
any, on the Securities of the Series will be made; 
 2.2.19 if payments of principal of or interest, if any, on
the Securities of the Series are to be made in one or more currencies or currency units other than that or those in which such Securities are denominated, the manner in which the exchange rate with respect to such payments will be determined;

 2.2.20 the manner in which the amounts of payment of principal of or interest, if any, on the Securities of
the Series will be determined, if such amounts may be determined by reference to an index based on a currency or currencies or by reference to a commodity, commodity index, stock exchange index or financial index; 

2.2.21 the provisions, if any, relating to any security provided for the Securities of the Series; 

2.2.22 any addition to or change in the Events of Default which apply to any Securities of the Series and any change in
the right of the Trustee or the requisite Holders of such Securities to declare the principal amount thereof due and payable pursuant to Section 6.2; 

  
 -8-

 2.2.23 any addition to or change in the covenants set forth in Article IV or
V which applies to Securities of the Series; 
 2.2.24 any other terms of the Securities of the Series (which
terms shall not be inconsistent with the provisions of this Indenture, except as permitted by Section 9.1, but which may modify or delete any provision of this Indenture insofar as it applies to such Series); 

2.2.25 any provisions granting special rights to holders when a specified event occurs; and 

2.2.26 any depositories, interest rate calculation agents, exchange rate calculation agents or other agents with respect
to Securities of such Series if other than those appointed herein. 
 All Securities of any one Series need not
be issued at the same time and may be issued from time to time, consistent with the terms of this Indenture, if so provided by or pursuant to the Board Resolution, supplemental indenture hereto or Officers’ Certificate referred to above, and
the authorized principal amount of any Series may not be increased to provide for issuances of additional Securities of such Series, unless otherwise provided in such Board Resolution, supplemental indenture hereto or Officers’ Certificate.

 Section 2.3 Execution and Authentication. 

Two Officers shall sign the Securities for the Company by manual or facsimile signature. 

If an Officer whose signature is on a Security no longer holds that office at the time the Security is authenticated, the
Security shall nevertheless be valid. 
 A Security shall not be valid until authenticated by the manual
signature of the Trustee or an authenticating agent. The signature shall be conclusive evidence that the Security has been authenticated under this Indenture. 
 The Trustee shall at any time, and from time to time, authenticate Securities for original issue in the principal amount provided in the Board Resolution, supplemental indenture hereto or Officers’
Certificate, upon receipt by the Trustee of a Company Order. Such Company Order may authorize authentication and delivery pursuant to oral or electronic instructions from the Company or its duly authorized agent or agents, which oral instructions
shall be promptly confirmed in writing. 
 Each Security shall be dated the date of its authentication unless
otherwise provided by a Board Resolution, a supplemental indenture hereto or an Officers’ Certificate. 

The aggregate principal amount of Securities of any Series outstanding at any time may not exceed any limit upon the
maximum principal amount for such Series set forth in the Board Resolution, supplemental indenture hereto or Officers’ Certificate delivered pursuant to Section 2.2, except as provided in Section 2.8. 

  
 -9-

 Prior to the issuance of Securities of any Series, the Trustee shall have
received and (subject to Section 7.2) shall be fully protected in relying on: (a) the Board Resolution, supplemental indenture hereto or Officers’ Certificate establishing the form of the Securities of that Series or of Securities
within that Series and the terms of the Securities of that Series or of Securities within that Series, (b) an Officers’ Certificate complying with Section 10.4, and (c) an Opinion of Counsel complying with Section 10.4.

 The Trustee shall have the right to decline to authenticate and deliver any Securities of such Series:
(a) if the Trustee, being advised by counsel, determines that such action may not lawfully be taken; or (b) if the Trustee in good faith by its board of directors or trustees, executive committee or a trust committee of directors and/or
vice-presidents shall determine that such action would expose the Trustee to personal liability to Holders of any then outstanding Series of Securities. 
 The Trustee may appoint an authenticating agent acceptable to the Company to authenticate Securities. An authenticating agent may authenticate Securities whenever the Trustee may do so. Each reference in
this Indenture to authentication by the Trustee includes authentication by such agent. An authenticating agent has the same rights as an Agent to deal with the Company or an Affiliate. 

Section 2.4 Registrar and Paying Agent. 

The Company shall maintain, with respect to each Series of Securities, at the place or places specified with respect to
such Series pursuant to Section 2.2, an office or agency where Securities of such Series may be presented or surrendered for payment (“PAYING AGENT”), where Securities of such Series may be surrendered for registration of transfer or
exchange (“REGISTRAR”) and where notices and demands to or upon the Company in respect of the Securities of such Series and this Indenture may be served (“SERVICE AGENT”). The Registrar shall keep a register with respect to each
Series of Securities and to their transfer and exchange. The Company will give prompt written notice to the Trustee of the name and address, and any change in the name or address, of each Registrar, Paying Agent or Service Agent. If at any time the
Company shall fail to maintain any such required Registrar, Paying Agent or Service Agent or shall fail to furnish the Trustee with the name and address thereof, such presentations, surrenders, notices and demands may be made or served at the
Corporate Trust Office of the Trustee, and the Company hereby appoints the Trustee as its agent to receive all such presentations, surrenders, notices and demands. 

The Company may also from time to time designate one or more co-registrars, additional paying agents or additional service
agents and may from time to time rescind such designations; provided, however, that no such designation or rescission shall in any manner relieve the Company of its obligations to maintain a Registrar, Paying Agent and Service Agent in each place so
specified pursuant to Section 2.2 for Securities of any Series for such purposes. The Company will give prompt written notice to the Trustee of any such designation or rescission and of any change in the name or address of any such
co-registrar, additional paying agent or additional service agent. The term “REGISTRAR” includes any co-registrar; the term “PAYING AGENT” includes any additional paying agent; and the term “SERVICE AGENT” includes any
additional service agent. 

  
 -10-

 The Company hereby appoints the Trustee the initial Registrar, Paying Agent
and Service Agent for each Series unless another Registrar, Paying Agent or Service Agent, as the case may be, is appointed prior to the time Securities of that Series are first issued. 

Section 2.5 Paying Agent to Hold Money in Trust. 

The Company shall require each Paying Agent other than the Trustee to agree in writing that the Paying Agent will hold in
trust, for the benefit of Securityholders of any Series of Securities, or the Trustee, all money held by the Paying Agent for the payment of principal or interest on the Series of Securities, and will notify the Trustee of any default by the Company
in making any such payment. While any such default continues, the Trustee may require a Paying Agent to pay all money held by it to the Trustee. The Company at any time may require a Paying Agent to pay all money held by it to the Trustee. Upon
payment over to the Trustee, the Paying Agent (if other than the Company or a Subsidiary) shall have no further liability for the money. If the Company or a Subsidiary acts as Paying Agent, it shall segregate and hold in a separate trust fund for
the benefit of Securityholders of any Series of Securities all money held by it as Paying Agent. 
 Section 2.6
Securityholder Lists. 
 The Trustee shall preserve in as current a form as is reasonably
practicable the most recent list available to it of the names and addresses of Securityholders of each Series of Securities and shall otherwise comply with TIA Section 312(a). If the Trustee is not the Registrar, the Company shall furnish to
the Trustee at least ten days before each interest payment date and at such other times as the Trustee may request in writing a list, in such form and as of such date as the Trustee may reasonably require, of the names and addresses of
Securityholders of each Series of Securities. 
 Section 2.7 Transfer and Exchange. 

Where Securities of a Series are presented to the Registrar or a co-registrar with a request to register a transfer or to
exchange them for an equal principal amount of Securities of the same Series, the Registrar shall register the transfer or make the exchange if its requirements for such transactions are met. To permit registrations of transfers and exchanges, the
Trustee shall authenticate Securities at the Registrar’s request. No service charge shall be made for any registration of transfer or exchange (except as otherwise expressly permitted herein), but the Company may require payment of a sum
sufficient to cover any transfer tax or similar governmental charge payable in connection therewith (other than any such transfer tax or similar governmental charge payable upon exchanges pursuant to Section 2.11, 3.6 or 9.6). 

Neither the Company nor the Registrar shall be required (a) to issue, register the transfer of, or exchange
Securities of any Series for the period beginning at the opening of business fifteen days immediately preceding the mailing of a notice of redemption of Securities of that Series selected for redemption and ending at the close of business on the day
of such mailing, or (b) to register the transfer of or exchange Securities of any Series selected, called or being called for redemption as a whole or the portion being redeemed of any such Securities selected, called or being called for
redemption in part. 

  
 -11-

 Section 2.8 Mutilated, Destroyed, Lost and Stolen Securities. 

If any mutilated Security is surrendered to the Trustee, the Company shall execute and the Trustee shall authenticate and
deliver in exchange therefor a new Security of the same Series and of like tenor and principal amount and bearing a number not contemporaneously outstanding. 
 If there shall be delivered to the Company and the Trustee (i) evidence to their satisfaction of the destruction, loss or theft of any Security and (ii) such security or indemnity as may be
required by them to save each of them and any agent of either of them harmless, then, in the absence of notice to the Company or the Trustee that such Security has been acquired by a bona fide purchaser, the Company shall execute and upon its
request the Trustee shall authenticate and make available for delivery, in lieu of any such destroyed, lost or stolen Security, a new Security of the same Series and of like tenor and principal amount and bearing a number not contemporaneously
outstanding. 
 In case any such mutilated, destroyed, lost or stolen Security has become or is about to become
due and payable, the Company in its discretion may, instead of issuing a new Security, pay such Security. 
 Upon
the issuance of any new Security under this Section, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and
expenses of the Trustee) connected therewith. 
 Every new Security of any Series issued pursuant to this Section
in lieu of any destroyed, lost or stolen Security shall constitute an original additional contractual obligation of the Company, whether or not the destroyed, lost or stolen Security shall be at any time enforceable by anyone, and shall be entitled
to all the benefits of this Indenture equally and proportionately with any and all other Securities of that Series duly issued hereunder. 
 The provisions of this Section are exclusive and shall preclude (to the extent lawful) all other rights and remedies with respect to the replacement or payment of mutilated, destroyed, lost or stolen
Securities. 
 Section 2.9 Outstanding Securities. 

The Securities outstanding at any time are all the Securities authenticated by the Trustee except for those canceled by
it, those delivered to it for cancellation, those reductions in the interest on a Global Security effected by the Trustee in accordance with the provisions hereof and those described in this Section as not outstanding. 

If a Security is replaced pursuant to Section 2.8, it ceases to be outstanding until the Trustee receives proof
satisfactory to it that the replaced Security is held by a bona fide purchaser. 
 If the Paying Agent (other
than the Company, a Subsidiary or an Affiliate of any thereof) holds on the Maturity of Securities of a Series money sufficient to pay such Securities 

  
 -12-

 
payable on that date, then on and after that date such Securities of the Series cease to be outstanding and interest on them ceases to accrue. 

A Security does not cease to be outstanding because the Company or an Affiliate of the Company holds the Security.

 In determining whether the Holders of the requisite principal amount of outstanding Securities have given any
request, demand, authorization, direction, notice, consent or waiver hereunder, the principal amount of a Discount Security that shall be deemed to be outstanding for such purposes shall be the amount of the principal thereof that would be due and
payable as of the date of such determination upon a declaration of acceleration of the Maturity thereof pursuant to Section 6.2. 
 Section 2.10 Treasury Securities. 
 In determining
whether the Holders of the required principal amount of Securities of a Series have concurred in any request, demand, authorization, direction, notice, consent or waiver Securities of a Series owned by the Company or an Affiliate of the Company
shall be disregarded, except that for the purposes of determining whether the Trustee shall be protected in relying on any such request, demand, authorization, direction, notice, consent or waiver, only Securities of a Series that the Trustee knows
are so owned shall be so disregarded. 
 Section 2.11 Temporary Securities. 

Until definitive Securities are ready for delivery, the Company may prepare and the Trustee shall authenticate temporary
Securities upon a Company Order. Temporary Securities shall be substantially in the form of definitive Securities but may have variations that the Company considers appropriate for temporary Securities. Without unreasonable delay, the Company shall
prepare and the Trustee upon request shall authenticate definitive Securities of the same Series and date of maturity in exchange for temporary Securities. Until so exchanged, temporary securities shall have the same rights under this Indenture as
the definitive Securities. 
 Section 2.12 Cancellation. 

The Company at any time may deliver Securities to the Trustee for cancellation. The Registrar and the Paying Agent shall
forward to the Trustee any Securities surrendered to them for registration of transfer, exchange or payment. The Trustee shall cancel all Securities surrendered for transfer, exchange, payment, replacement or cancellation and shall destroy such
canceled Securities (subject to the record retention requirement of the Exchange Act) and deliver a certificate of such destruction to the Company, unless the Company otherwise directs. The Company may not issue new Securities to replace Securities
that it has paid or delivered to the Trustee for cancellation. 
 Section 2.13 Defaulted Interest. 

If the Company defaults in a payment of interest on a Series of Securities, it shall pay the defaulted interest, plus, to
the extent permitted by law, any interest payable on the defaulted interest, to the Persons who are Securityholders of the Series on a subsequent special 

  
 -13-

 
record date. The Company shall fix the record date and payment date. At least 30 days before the record date, the Company shall mail to the Trustee and to each Securityholder of the Series a
notice that states the record date, the payment date and the amount of interest to be paid. The Company may pay defaulted interest in any other lawful manner. 
 Section 2.14 Global Securities. 
 2.14.1 Terms of
Securities. A Board Resolution, a supplemental indenture hereto or an Officers’ Certificate shall establish whether the Securities of a Series shall be issued in whole or in part in the form of one or more Global Securities and the Depository
for such Global Security or Securities. 
 2.14.2 Transfer and Exchange. Notwithstanding any provisions to the
contrary contained in Section 2.7 and in addition thereto, any Global Security shall be exchangeable pursuant to Section 2.7 for Securities registered in the names of Holders other than the Depository for such Security or its nominee only
if (i) such Depository notifies the Company that it is unwilling or unable to continue as Depository for such Global Security or if at any time such Depository ceases to be a clearing agency registered under the Exchange Act, and, in either
case, the Company fails to appoint a successor Depository within 90 days of such event, (ii) the Company executes and delivers to the Trustee an Officers’ Certificate to the effect that such Global Security shall be so exchangeable or
(iii) an Event of Default with respect to the Securities represented by such Global Security shall have happened and be continuing. Any Global Security that is exchangeable pursuant to the preceding sentence shall be exchangeable for Securities
registered in such names as the Depository shall direct in writing in an aggregate principal amount equal to the principal amount of the Global Security with like tenor and terms. 

Except as provided in this Section 2.14.2, a Global Security may not be transferred except as a whole by the
Depository with respect to such Global Security to a nominee of such Depository, by a nominee of such Depository to such Depository or another nominee of such Depository or by the Depository or any such nominee to a successor Depository or a nominee
of such a successor Depository. 
 2.14.3 Legend. Unless otherwise provided pursuant to Section 2.2, any
Global Security issued hereunder shall bear a legend in substantially the following form: 
 “THIS SECURITY IS A GLOBAL SECURITY WITHIN THE
MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY OR A NOMINEE OF THE DEPOSITORY. THIS SECURITY IS EXCHANGEABLE FOR SECURITIES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITORY OR ITS NOMINEE
ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITORY TO A NOMINEE OF THE DEPOSITORY, BY A NOMINEE OF THE DEPOSITORY TO THE DEPOSITORY OR ANOTHER NOMINEE OF THE DEPOSITORY OR BY
THE DEPOSITORY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITORY OR A NOMINEE OF SUCH A SUCCESSOR DEPOSITORY.” 

  
 -14-

 2.14.4 Acts of Holders. The Depository, as a Holder, may appoint agents and
otherwise authorize participants to give or take any request, demand, authorization, direction, notice, consent, waiver or other action which a Holder is entitled to give or take under the Indenture. 

2.14.5 Payments. Notwithstanding the other provisions of this Indenture, unless otherwise specified as contemplated by
Section 2.2, payment of the principal of, premium, if any, and interest, if any, on any Global Security shall be made to the Holder thereof. 
 2.14.6 Consents, Declaration and Directions. Except as provided in Section 2.14.5, the Company, the Trustee and any Agent shall treat a Person as the Holder of such principal amount of outstanding
Securities of such Series represented by a Global Security as shall be specified in a written statement of the Depositary with respect to such Global Security, for purposes of obtaining any consents, declarations, waivers or directions required to
be given by the Holders pursuant to this Indenture. 
 Section 2.15 CUSIP Numbers. 

The Company in issuing the Securities may use “CUSIP” numbers (if then generally in use), and, if so, the
Trustee shall use “CUSIP” numbers in notices of redemption as a convenience to Holders; provided that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Securities or as
contained in any notice of a redemption and that reliance may be placed only on the other elements of identification printed on the Securities, and any such redemption shall not be affected by any defect in or omission of such numbers. 

ARTICLE III. 

REDEMPTION 

Section 3.1 Notice to Trustee. 
 The Company may, with respect to any Series of Securities, reserve the right to redeem and pay the Series of Securities or may covenant to redeem and pay the Series of Securities or any part thereof prior
to the Stated Maturity thereof at such time and on such terms as provided for in such Securities. If a Series of Securities is redeemable and the Company wants or is obligated to redeem prior to the Stated Maturity thereof all or part of the Series
of Securities pursuant to the terms of such Securities, it shall notify the Trustee of the redemption date and the principal amount of Series of Securities to be redeemed. The Company shall give the notice at least 45 days before the redemption date
(or such shorter notice as may be acceptable to the Trustee). 
 Section 3.2 Selection of Securities to be
Redeemed. 
 Unless otherwise indicated for a particular Series by a Board Resolution, a supplemental
indenture hereto or an Officers’ Certificate, if less than all the Securities of a Series are to be redeemed, the Trustee shall select the Securities of the Series to be redeemed in any manner that the Trustee deems fair and appropriate. The
Trustee shall make the selection from Securities of the Series outstanding not previously called for redemption. The Trustee may 

  
 -15-

 
select for redemption portions of the principal of Securities of the Series that have denominations larger than $1,000. Securities of the Series and portions of them it selects shall be in
amounts of $1,000 or whole multiples of $1,000 or, with respect to Securities of any Series issuable in other denominations pursuant to Section 2.2.13, the minimum principal denomination for each Series and integral multiples thereof.
Provisions of this Indenture that apply to Securities of a Series called for redemption also apply to portions of Securities of that Series called for redemption. 
 Section 3.3 Notice of Redemption. 
 Unless otherwise
indicated for a particular Series by Board Resolution, a supplemental indenture hereto or an Officers’ Certificate, at least 30 days but not more than 90 days before a redemption date, the Company shall mail a notice of redemption by
first-class mail to each Holder whose Securities are to be redeemed and if any Bearer Securities are outstanding, publish on one occasion a notice in an Authorized Newspaper. The notice shall identify the Securities of the Series to be redeemed and
shall state: 
 (a) the redemption date; 

(b) the redemption price, or if not then ascertainable, the manner of calculation thereof; 

(c) the name and address of the Paying Agent; 

(d) that Securities of the Series called for redemption must be surrendered to the Paying Agent to collect the redemption
price; 
 (e) if fewer than all the outstanding Securities of the Series are to be redeemed, the identification
and principal amounts of the particular Securities of the Series to be redeemed; 
 (f) that interest on
Securities of the Series called for redemption ceases to accrue on and after the redemption date; 
 (g) that no
representation is made as to the correctness or accuracy of the CUSIP number, if any, listed in such notice or printed on the Securities; and 
 (h) any other information as may be required by the terms of the particular Series or the Securities of a Series being redeemed. 

At the Company’s request, the Trustee shall give the notice of redemption in the Company’s name and at its
expense. 
 Section 3.4 Effect of Notice of Redemption. 

Once notice of redemption is mailed or published as provided in Section 3.3, Securities of a Series called for
redemption become due and payable on the redemption date and at the redemption price. A notice of redemption may not be conditional. If mailed in the manner provided for in Section 3.3, the notice of redemption shall be conclusively presumed to
have 

  
 -16-

 
been given whether or not the Holder receives such notice. Failure to give such notice or any defect in the notice to any Holder shall not affect the validity of the notice or the redemption.
Upon surrender to the Paying Agent, such Securities shall be paid at the redemption price plus accrued interest to the redemption date. 
 Section 3.5 Deposit of Redemption Price. 
 On or
before the redemption date, the Company shall deposit with the Paying Agent money sufficient to pay the redemption price of and accrued interest, if any, on all Securities to be redeemed on that date. 

Section 3.6 Securities Redeemed in Part. 

Upon surrender of a Security that is redeemed in part, the Trustee shall authenticate for the Holder a new Security of the
same Series and the same maturity equal in principal amount to the unredeemed portion of the Security surrendered. 
 ARTICLE IV.

 COVENANTS 
 Section 4.1 Payment of Principal and Interest. 
 The
Company covenants and agrees for the benefit of the Holders of each Series of Securities that it will duly and punctually pay the principal of and interest, if any, on the Securities of that Series in accordance with the terms of such Securities and
this Indenture. 
 Section 4.2 SEC Reports. 

The Company shall deliver to the Trustee within 30 days after it files them with the SEC copies of the annual reports and
of the information, documents, and other reports (or copies of such portions of any of the foregoing as the SEC may by rules and regulations prescribe) which the Company is required to file with the SEC pursuant to Section 13 or 15(d) of the
Exchange Act. The Company also shall comply with the other provisions of TIA Section 314(a). 
 Section 4.3 Compliance
Certificate. 
 The Company shall deliver to the Trustee, within 120 days after the end of each fiscal
year of the Company, an Officers’ Certificate stating that a review of the activities of the Company and its Subsidiaries during the preceding fiscal year has been made under the supervision of the signing Officers with a view to determining
whether the Company has kept, observed, performed and fulfilled its obligations under this Indenture, and further stating, as to each such Officer signing such certificate, that to the best of his knowledge the Company has kept, observed, performed
and fulfilled each and every covenant contained in this Indenture and is not in default in the performance or observance of any of the terms, provisions and conditions hereof (or, if a Default or Event of Default shall have occurred, describing all
such Defaults or Events of Default of which he may have knowledge). 

  
 -17-

 The Company will, so long as any of the Securities are outstanding, deliver
to the Trustee, forthwith upon becoming aware of any Default or Event of Default, an Officers’ Certificate specifying such Default or Event of Default and what action the Company is taking or proposes to take with respect thereto. 

Section 4.4 Stay, Extension and Usury Laws. 

The Company covenants (to the extent that it may lawfully do so) that it will not at any time insist upon, plead, or in
any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law wherever enacted, now or at any time hereafter in force, which may affect the covenants or the performance of this Indenture or the Securities; and the
Company (to the extent it may lawfully do so) hereby expressly waives all benefit or advantage of any such law and covenants that it will not, by resort to any such law, hinder, delay or impede the execution of any power herein granted to the
Trustee, but will suffer and permit the execution of every such power as though no such law has been enacted. 
 Section 4.5
Maintenance of Office or Agency. 
 So long as any Series of Securities remains outstanding, the
Company agrees to maintain an office or agency in the Borough of Manhattan, the City and State of New York, with respect to each such Series and at such other location or locations as may be designated as provided in this Section 4.5, where
(a) Securities of that Series may be presented for payment, (b) Securities of that Series may be presented as hereinabove authorized for registration of transfer and exchange, and (c) notices and demands to or upon the Company in
respect of the Securities of that Series and this Indenture may be given or served, such designation to continue with respect to such office or agency until the Company shall, by written notice signed by an Officer of the Company and delivered to
the Trustee, designate some other office or agency for such purposes or any of them. If at any time the Company shall fail to maintain any such required office or agency or shall fail to furnish the Trustee with the address thereof, such
presentations, notices and demands may be made or served at the Corporate Trust Office of the Trustee, and the Company hereby appoints the Trustee as its agent to receive all such presentations, notices and demands. 

Section 4.6 Corporate Existence. 
 Subject to Article V, the Company will do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence and the corporate, partnership or other existence
of each Subsidiary in accordance with the respective organizational documents of each Subsidiary and the rights (charter and statutory), licenses and franchises of the Company and its Subsidiaries; provided, however, that the Company shall not be
required to preserve any such right, license or franchise, or the corporate, partnership or other existence of any Subsidiary, if the Company shall determine that the preservation thereof is no longer desirable in the conduct of the business of the
Company and its Subsidiaries taken as a whole and that the loss thereof is not adverse in any material respect to the Holders. 

  
 -18-

 Section 4.7 Taxes. 

The Company shall, and shall cause each of its Subsidiaries to, pay prior to delinquency all material taxes, assessments
and governmental levies, except as contested in good faith and by appropriate proceedings. 
 ARTICLE V. 

SUCCESSORS 

Section 5.1 Successor Corporation Substituted. 

Upon any consolidation or merger, or any sale, lease, conveyance or other disposition of all or substantially all of the
assets of the Company, the successor corporation formed by such consolidation or into or with which the Company is merged or to which such sale, lease, conveyance or other disposition is made shall succeed to, and be substituted for, and may
exercise every right and power of, the Company under this Indenture with the same effect as if such successor Person has been named as the Company herein. 
 ARTICLE VI. 
 DEFAULTS AND REMEDIES 

Section 6.1 Events of Default. 
 “EVENT OF DEFAULT,” wherever used herein with respect to Securities of any Series, means any one of the following events, unless in the establishing Board Resolution, supplemental indenture
hereto or Officers’ Certificate, it is provided that such Series shall not have the benefit of said Event of Default: 
 (a) default in the payment of any interest on any Security of that Series when it becomes due and payable, and continuance of such default for a period of 30 days (unless the entire amount of such payment
is deposited by the Company with the Trustee or with a Paying Agent prior to the expiration of such period of 30 days); or 
 (b) default in the payment of the principal of any Security of that Series at its Maturity; or 
 (c) default in the deposit of any sinking fund payment, when and as due in respect of any Security of that Series; or 

(d) default in the performance or breach of any covenant or warranty of the Company in this Indenture (other than a
covenant or warranty that has been included in this Indenture solely for the benefit of a Series of Securities other than that Series), which default continues uncured for a period of 60 days after there has been given, by registered or certified
mail, to the Company by the Trustee or to the Company and the Trustee by the Holders of at least 25% in principal amount of the outstanding Securities of that Series a written notice specifying such default or breach and requiring it to be remedied
and stating that such notice is a “NOTICE OF DEFAULT” hereunder; or 

  
 -19-

 (e) the Company or any of its Significant Subsidiaries pursuant to or within
the meaning of any Bankruptcy Law: 
 (i) commences a voluntary case, 

(ii) consents to the entry of an order for relief against it in an involuntary case, 

(iii) consents to the appointment of a Custodian of it or for all or substantially all of its property, 

(iv) makes a general assignment for the benefit of its creditors, or 

(f) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: 

(i) is for relief against the Company or any of its Significant Subsidiaries in an involuntary case, 

(ii) appoints a Custodian of the Company or any of its Significant Subsidiaries or for all or substantially all of its
property, or 
 (iii) orders the liquidation of the Company or any of its Significant Subsidiaries, and the
order or decree remains unstayed and in effect for 90 days; or 
 (g) any other Event of Default provided with
respect to Securities of that Series, which is specified in a Board Resolution, a supplemental indenture hereto or an Officers’ Certificate, in accordance with Section 2.2. 

The term “BANKRUPTCY LAW” means title 11, U.S. Code or any similar Federal or State law for the relief of
debtors. The term “CUSTODIAN” means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law. 
 Section 6.2 Acceleration of Maturity; Rescission and Annulment. 
 If an Event of Default with respect to Securities of any Series at the time outstanding occurs and is continuing (other than an Event of Default referred to in Section 6.1(e) or (f)), then in every
such case the Trustee or the Holders of not less than 25% in principal amount of the outstanding Securities of that Series may declare the principal amount (or, if any Securities of that Series are Discount Securities, such portion of the principal
amount as may be specified in the terms of such Securities) of and accrued and unpaid interest, if any, on all of the Securities of that Series to be due and payable immediately, by a notice in writing to the Company (and to the Trustee if given by
Holders), and upon any such declaration such principal amount (or specified amount) and accrued and unpaid interest, if any, shall become immediately due and payable. If an Event of Default specified in Section 6.1(e) or (f) shall occur,
the principal amount (or specified amount) of and accrued and unpaid interest, if any, on all 

  
 -20-

 
outstanding Securities shall ipso facto become and be immediately due and payable without any declaration or other act on the part of the Trustee or any Holder. 

At any time after such a declaration of acceleration with respect to any Series has been made and before a judgment or
decree for payment of the money due has been obtained by the Trustee as hereinafter in this Article provided, the Holders of a majority in principal amount of the outstanding Securities of that Series, by written notice to the Company and the
Trustee, may rescind and annul such declaration and its consequences if: 
 (a) the Company has paid or deposited
with the Trustee a sum sufficient to pay 
 (i) all overdue interest, if any, on all Securities of that Series,

 (ii) the principal of any Securities of that Series which have become due otherwise than by such declaration
of acceleration and interest thereon at the rate or rates prescribed therefor in such Securities, 
 (iii) to
the extent that payment of such interest is lawful, interest upon any overdue principal and overdue interest at the rate or rates prescribed therefor in such Securities, and 

(iv) all sums paid or advanced by the Trustee hereunder and the reasonable compensation, expenses, disbursements and
advances of the Trustee, its agents and counsel; and 
 (b) all Events of Default with respect to Securities of
that Series, other than the non-payment of the principal (or a specified portion of the principal) of Securities of that Series which have become due solely by such declaration of acceleration, have been cured or waived as provided in
Section 6.13. 
 No such rescission shall affect any subsequent Default or impair any right consequent
thereon. 
 Section 6.3 Collection of Indebtedness and Suits for Enforcement by Trustee. 

The Company covenants that if 
 (a) default is made in the payment of any interest on any Security when such interest becomes due and payable and such default continues for a period of 30 days, or 

(b) default is made in the payment of principal of any Security at the Maturity thereof, or 

(c) default is made in the deposit of any sinking fund payment when and as due by the terms of a Security, 

  
 -21-

 then, the Company will, upon demand of the Trustee, pay to it, for the benefit of the Holders of such
Securities, the whole amount then due and payable on such Securities for principal and interest and, to the extent that payment of such interest shall be legally enforceable, interest on any overdue principal or any overdue interest, at the rate or
rates prescribed therefor in such Securities, and, in addition thereto, such further amount as shall be sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances of the
Trustee, its agents and counsel. 
 If the Company fails to pay such amounts forthwith upon such demand, the
Trustee, in its own name and as trustee of an express trust, may institute a judicial proceeding for the collection of the sums so due and unpaid, may prosecute such proceeding to judgment or final decree and may enforce the same against the Company
or any other obligor upon such Securities and collect the moneys adjudged or deemed to be payable in the manner provided by law out of the property of the Company or any other obligor upon such Securities, wherever situated. 

If an Event of Default with respect to any Securities of any Series occurs and is continuing, the Trustee may in its
discretion proceed to protect and enforce its rights and the rights of the Holders of Securities of such Series by such appropriate judicial proceedings as the Trustee shall deem most effectual to protect and enforce any such rights, whether for the
specific enforcement of any covenant or agreement in this Indenture or in aid of the exercise of any power granted herein, or to enforce any other proper remedy. 
 Section 6.4 Trustee May File Proofs of Claim. 
 In
case of the pendency of any receivership, insolvency, liquidation, bankruptcy, reorganization, arrangement, adjustment, composition or other judicial proceeding relative to the Company or any other obligor upon the Securities or the property of the
Company or of such other obligor or their creditors, the Trustee (irrespective of whether the principal of the Securities shall then be due and payable as therein expressed or by declaration or otherwise and irrespective of whether the Trustee shall
have made any demand on the Company for the payment of overdue principal or interest) shall be entitled and empowered, by intervention in such proceeding or otherwise, 

(a) to file and prove a claim for the whole amount of principal and interest owing and unpaid in respect of the Securities
and to file such other papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel)
and of the Holders allowed in such judicial proceeding, and 
 (b) to collect and receive any moneys or other
property payable or deliverable on any such claims and to distribute the same, and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Holder to
make such payments to the Trustee and, in the event that the Trustee shall consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due it for the reasonable compensation, expenses, disbursements and advances
of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 7.7. 

  
 -22-

 Nothing herein contained shall be deemed to authorize the Trustee to
authorize or consent to or accept or adopt on behalf of any Holder any plan of reorganization, arrangement, adjustment or composition affecting the Securities or the rights of any Holder thereof or to authorize the Trustee to vote in respect of the
claim of any Holder in any such proceeding. 
 Section 6.5 Trustee May Enforce Claims Without Possession of
Securities. 
 All rights of action and claims under this Indenture or the Securities may be
prosecuted and enforced by the Trustee without the possession of any of the Securities or the production thereof in any proceeding relating thereto, and any such proceeding instituted by the Trustee shall be brought in its own name as trustee of an
express trust, and any recovery of judgment shall, after provision for the payment of the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, be for the ratable benefit of the Holders of the
Securities in respect of which such judgment has been recovered. 
 Section 6.6 Application of Money Collected.

 Any money collected by the Trustee pursuant to this Article shall be applied in the following order, at the
date or dates fixed by the Trustee and, in case of the distribution of such money on account of principal or interest, upon presentation of the Securities and the notation thereon of the payment if only partially paid and upon surrender thereof if
fully paid: 
 First: To the payment of all amounts due the Trustee under Section 7.7; and 

Second: To the payment of the amounts then due and unpaid for principal of and interest on the Securities in respect of
which or for the benefit of which such money has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable on such Securities for principal and interest, respectively; and 

Third: To the Company. 
 The Trustee may fix a record date and payment date for any payment to Securityholders pursuant to this Section 6.6. At least 15 days before such record date, the Company shall mail to each
Securityholder and the Trustee a notice that states the record date, the payment date and the amount to be paid. 
 Section 6.7
Limitation on Suits. 
 No Holder of any Security of any Series shall have any right to institute any
proceeding, judicial or otherwise, with respect to this Indenture, or for the appointment of a receiver or trustee, or for any other remedy hereunder, unless 
 (a) such Holder has previously given written notice to the Trustee of a continuing Event of Default with respect to the Securities of that Series; 

  
 -23-

 (b) the Holders of not less than 25% in principal amount of the outstanding
Securities of that Series shall have made written request to the Trustee to institute proceedings in respect of such Event of Default in its own name as Trustee hereunder; 

(c) such Holder or Holders have offered to the Trustee reasonable indemnity against the costs, expenses and liabilities to
be incurred in compliance with such request; 
 (d) the Trustee for 90 days after its receipt of such notice,
request and offer of indemnity has failed to institute any such proceeding; and 
 (e) no direction inconsistent
with such written request has been given to the Trustee during such 90-day period by the Holders of a majority in principal amount of the outstanding Securities of that Series; 
 it being understood and intended that no one or more of such Holders shall have any right in any manner whatever by virtue of, or by availing of, any provision of this Indenture to affect, disturb or
prejudice the rights of any other of such Holders, or to obtain or to seek to obtain priority or preference over any other of such Holders or to enforce any right under this Indenture, except in the manner herein provided and for the equal and
ratable benefit of all such Holders. 
 Section 6.8 Unconditional Right of Holders to Receive Principal and
Interest. 
 Notwithstanding any other provision in this Indenture, the Holder of any Security shall
have the right, which is absolute and unconditional, to receive payment of the principal of and interest, if any, on such Security on the Stated Maturity or Stated Maturities expressed in such Security (or, in the case of redemption, on the
redemption date) and to institute suit for the enforcement of any such payment, and such rights shall not be impaired without the consent of such Holder. 
 Section 6.9 Restoration of Rights and Remedies. 
 If
the Trustee or any Holder has instituted any proceeding to enforce any right or remedy under this Indenture and such proceeding has been discontinued or abandoned for any reason, or has been determined adversely to the Trustee or to such Holder,
then and in every such case, subject to any determination in such proceeding, the Company, the Trustee and the Holders shall be restored severally and respectively to their former positions hereunder and thereafter all rights and remedies of the
Trustee and the Holders shall continue as though no such proceeding had been instituted. 
 Section 6.10 Rights and Remedies
Cumulative. 
 Except as otherwise provided with respect to the replacement or payment of mutilated,
destroyed, lost or stolen Securities in Section 2.8, no right or remedy herein conferred upon or reserved to the Trustee or to the Holders is intended to be exclusive of any other right or remedy, and every right and remedy shall, to the extent
permitted by law, be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not
prevent the concurrent assertion or employment of any other appropriate right or remedy. 

  
 -24-

 Section 6.11 Delay or Omission Not Waiver. 

No delay or omission of the Trustee or of any Holder of any Securities to exercise any right or remedy accruing upon any
Event of Default shall impair any such right or remedy or constitute a waiver of any such Event of Default or an acquiescence therein. Every right and remedy given by this Article or by law to the Trustee or to the Holders may be exercised from time
to time, and as often as may be deemed expedient, by the Trustee or by the Holders, as the case may be. 
 Section 6.12
Control by Holders. 
 The Holders of a majority in principal amount of the outstanding Securities
of any Series shall have the right to direct the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee, with respect to the Securities of such Series;
provided that 
 (a) such direction shall not be in conflict with any rule of law or with this Indenture,

 (b) the Trustee may take any other action deemed proper by the Trustee which is not inconsistent with such
direction, and 
 (c) subject to the provisions of Section 6.1, the Trustee shall have the right to decline
to follow any such direction if the Trustee in good faith shall, by a Responsible Officer of the Trustee, determine that the proceeding so directed would involve the Trustee in personal liability. 

Section 6.13 Waiver of Past Defaults. 

Subject to Section 6.2, the Holders of not less than a majority in principal amount of the outstanding Securities of
any Series may on behalf of the Holders of all the Securities of such Series waive any past Default hereunder with respect to such Series and its consequences, except a Default in the payment of the principal of or interest on any Security of such
Series; provided, however, that the Holders of a majority in principal amount of the outstanding Securities of any Series may rescind an acceleration of the Securities of such Series and its consequences, including any related payment default that
resulted from such acceleration. Upon any such waiver, such Default shall cease to exist, and any Event of Default arising therefrom shall be deemed to have been cured, for every purpose of this Indenture; but no such waiver shall extend to any
subsequent or other Default or impair any right consequent thereon. 
 Section 6.14 Undertaking for Costs.

 All parties to this Indenture agree, and each Holder of any Security by his acceptance thereof shall be deemed
to have agreed, that any court may in its discretion require, in any suit for the enforcement of any right or remedy under this Indenture, or in any suit against 

  
 -25-

 
the Trustee for any action taken, suffered or omitted by it as Trustee, the filing by any party litigant in such suit of an undertaking to pay the costs of such suit, and that such court may in
its discretion assess reasonable costs, including reasonable attorneys’ fees, against any party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; but the provisions of
this Section shall not apply to any suit instituted by the Company, to any suit instituted by the Trustee, to any suit instituted by any Holder, or group of Holders, holding in the aggregate more than 10% in principal amount of the outstanding
Securities of any Series, or to any suit instituted by any Holder for the enforcement of the payment of the principal of or interest on any Security on or after the Stated Maturity or Stated Maturities expressed in such Security (or, in the case of
redemption, on the redemption date). 
 ARTICLE VII. 
 TRUSTEE 
 Section 7.1 Duties of Trustee. 

(a) If an Event of Default has occurred and is continuing, the Trustee shall exercise the rights and powers vested in it
by this Indenture and use the same degree of care and skill in their exercise as a prudent man would exercise or use under the circumstances in the conduct of his own affairs. 

(b) Except during the continuance of an Event of Default: 

(i) The Trustee need perform only those duties that are specifically set forth in this Indenture and no others.

 (ii) In the absence of bad faith on its part, the Trustee may conclusively rely, as to the truth of the
statements and the correctness of the opinions expressed therein, upon Officers’ Certificates or Opinions of Counsel furnished to the Trustee and conforming to the requirements of this Indenture; however, in the case of any such Officers’
Certificates or Opinions of Counsel which by any provisions hereof are specifically required to be furnished to the Trustee, the Trustee shall examine such Officers’ Certificates and Opinions of Counsel to determine whether or not they conform
to the requirements of this Indenture. 
 (c) The Trustee may not be relieved from liability for its own
negligent action, its own negligent failure to act or its own willful misconduct, except that: 
 (i) This
paragraph does not limit the effect of paragraph (b) of this Section. 
 (ii) The Trustee shall not be
liable for any error of judgment made in good faith by a Responsible Officer, unless it is proved that the Trustee was negligent in ascertaining the pertinent facts. 

(iii) The Trustee shall not be liable with respect to any action taken, suffered or omitted to be taken by it with respect
to Securities of any Series in good faith in accordance with the direction of the Holders of a majority in principal amount of the outstanding Securities of such Series relating to the time, method and place of conducting any

  
 -26-

 
proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee, under this Indenture with respect to the Securities of such Series. 

(d) Every provision of this Indenture that in any way relates to the Trustee is subject to paragraphs (a), (b) and
(c) of this Section. 
 (e) The Trustee may refuse to perform any duty or exercise any right or power unless
it receives indemnity satisfactory to it against any loss, liability or expense. 
 (f) The Trustee shall not be
liable for interest on any money received by it except as the Trustee may agree in writing with the Company. Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law. 

(g) No provision of this Indenture shall require the Trustee to risk its own funds or otherwise incur any financial
liability in the performance of any of its duties, or in the exercise of any of its rights or powers, if it shall have reasonable grounds for believing that repayment of such funds or adequate indemnity against such risk is not reasonably assured to
it. 
 (h) The Paying Agent, the Registrar and any authenticating agent shall be entitled to the protections and
immunities as are set forth in paragraphs (a), (b) and (c) of this Section with respect to the Trustee. 
 (i) Every provision of this Indenture relating to the conduct or affecting the liability of or affording protection to the Trustee shall be subject to the provisions of this Section and to the provisions
of the TIA and the provisions of this Article VII shall apply to the Trustee in its role as Registrar, Paying Agent and Service Agent. 
 Section 7.2 Rights of Trustee. 
 (a) The Trustee may
rely on and shall be protected in acting or refraining from acting upon any document believed by it to be genuine and to have been signed or presented by the proper Person. The Trustee need not investigate any fact or matter stated in the document.
The Trustee may, however, in its discretion make such further inquiry or investigation into such facts or matters as it may see fit. 
 (b) Before the Trustee acts or refrains from acting, it may require an Officers’ Certificate or an Opinion of Counsel. The Trustee shall not be liable for any action it takes or omits to take in good
faith in reliance on such Officers’ Certificate or Opinion of Counsel. 
 (c) The Trustee may act through
agents and shall not be responsible for the misconduct or negligence of any agent appointed with due care. No Depository shall be deemed an agent of the Trustee and the Trustee shall not be responsible for any act or omission by any Depository.

 (d) The Trustee shall not be liable for any action it takes or omits to take in good faith which it believes
to be authorized or within its rights or powers; provided that the Trustee’s conduct does not constitute willful misconduct or negligence. 

  
 -27-

 (e) The Trustee may consult with counsel and the advice of such counsel or
any Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken, suffered or omitted by it hereunder in good faith and in reliance thereon. 

(f) The permissive rights of the Trustee to do things enumerated in this Indenture shall not be construed as a duty unless
so specified herein. 
 (g) The Trustee shall be under no obligation to exercise any of the rights or powers
vested in it by this Indenture at the request or direction of any of the Holders of Securities unless such Holders shall have offered to the Trustee reasonable security or indemnity against the costs, expenses and liabilities which might be incurred
by it in compliance with such request or direction. 
 In addition, the Trustee shall not be deemed to have
knowledge of any Default or Event of Default except (1) any Event of Default occurring pursuant to Sections 6.1(a), 6.1(b), 6.1(c) and 4.3 hereof or (2) any Default or Event of Default of which the Trustee shall have received written
notification in the manner set forth in this Indenture or a Responsible Officer of the Trustee shall have obtained actual knowledge. Delivery of reports, information and documents to the Trustee under Section 4.2 is for informational purposes
only and the information and the Trustee’s receipt of the foregoing shall not constitute constructive notice of any information contained therein, or determinable from information contained therein including the Company’s compliance with
any of their covenants thereunder (as to which the Trustee is entitled to rely exclusively on an Officers’ Certificate). 

Section 7.3 Individual Rights of Trustee. 

The Trustee in its individual or any other capacity may become the owner or pledgee of Securities and may otherwise deal
with the Company or an Affiliate with the same rights it would have if it were not Trustee. Any Agent may do the same with like rights. The Trustee is also subject to Sections 7.10 and 7.11. 

Section 7.4 Trustee’s Disclaimer. 

The Trustee makes no representation as to the validity or adequacy of this Indenture or the Securities, it shall not be
accountable for the Company’s use of the proceeds from the Securities, and it shall not be responsible for any statement in any Security other than its authentication. 
 Section 7.5 Notice of Defaults. 
 If a Default or
Event of Default occurs and is continuing with respect to the Securities of any Series and if it is known to a Responsible Officer of the Trustee, the Trustee shall mail to each Securityholder of the Securities of that Series and, if any Bearer
Securities are outstanding, publish on one occasion in an Authorized Newspaper, notice of a Default or Event of Default within 90 days after it occurs or, if later, after a Responsible Officer of the Trustee has knowledge of such Default or Event of
Default. Except in the case of a Default or Event of Default in payment of principal of or interest on any Security of any Series, the Trustee may 

  
 -28-

 
withhold the notice if and so long as its corporate trust committee or a committee of its Responsible Officers in good faith determines that withholding the notice is in the interests of
Securityholders of that Series. 
 Section 7.6 Reports by Trustee to Holders. 

Within 60 days after May 15 in each year, the Trustee shall transmit by mail to all Securityholders, as their names
and addresses appear on the register kept by the Registrar and, if any Bearer Securities are outstanding, publish in an Authorized Newspaper, a brief report dated as of such May 15, in accordance with, and to the extent required under, TIA
Section 313. 
 A copy of each report at the time of its mailing to Securityholders of any Series shall be
filed with the SEC and each stock exchange on which the Securities of that Series are listed. The Company shall promptly notify the Trustee when Securities of any Series are listed on any stock exchange and of any delisting thereof. 

Section 7.7 Compensation and Indemnity. 
 The Company shall pay to the Trustee from time to time reasonable compensation for its services. The Trustee’s compensation shall not be limited by any law on compensation of a trustee of an express
trust. The Company shall reimburse the Trustee upon request for all reasonable out-of-pocket expenses incurred by it. Such expenses shall include the reasonable compensation and expenses of the Trustee’s agents and counsel. 

The Company shall indemnify the Trustee (including the cost of defending itself) against any loss, liability or expense
incurred by it except as set forth in the next paragraph in the performance of its duties under this Indenture as Trustee or Agent. The Trustee shall notify the Company promptly of any claim for which it may seek indemnity. The Company shall defend
the claim and the Trustee shall cooperate in the defense. The Trustee may have separate counsel and the Company shall pay the reasonable fees and expenses of such counsel. The Company need not pay for any settlement made without its consent, which
consent shall not be unreasonably withheld. This indemnification shall apply to officers, directors, employees, shareholders, agents, successors and assigns of the Trustee. 

The Company need not reimburse any expense or indemnify against any loss or liability incurred by the Trustee or by any
officer, director, employee, shareholder or agent of the Trustee through willful misconduct, negligence or bad faith. 
 To secure the Company’s payment obligations in this Section, the Trustee shall have a lien prior to the Securities of any Series on all money or property held or collected by the Trustee, except that
held in trust to pay principal and interest on particular Securities of that Series. 
 When the Trustee incurs
expenses or renders services after an Event of Default specified in Section 6.1(e) or (f) occurs, the expenses and the compensation for the services are intended to constitute expenses of administration under any Bankruptcy Law.

  
 -29-

 The provisions of this Section 7.7 shall survive the resignation or
removal of the Trustee and the termination of this Indenture. 
 Section 7.8 Replacement of Trustee. 

A resignation or removal of the Trustee and appointment of a successor Trustee shall become effective only upon the
successor Trustee’s acceptance of appointment as provided in this Section. 
 The Trustee may resign with
respect to the Securities of one or more Series by so notifying the Company. The Holders of a majority in principal amount of the Securities of any Series may remove the Trustee with respect to that Series by so notifying the Trustee and the
Company. The Company may remove the Trustee with respect to Securities of one or more Series if: 
 (a) the
Trustee fails to comply with Section 7.10; 
 (b) the Trustee is adjudged a bankrupt or an insolvent or an
order for relief is entered with respect to the Trustee under any Bankruptcy Law; 
 (c) a Custodian or public
officer takes charge of the Trustee or its property; or 
 (d) the Trustee becomes incapable of acting.

 If the Trustee resigns or is removed or if a vacancy exists in the office of Trustee for any reason, the
Company shall promptly appoint a successor Trustee. Within one year after the successor Trustee takes office, the Holders of a majority in principal amount of the then outstanding Securities may appoint a successor Trustee to replace the successor
Trustee appointed by the Company. 
 If a successor Trustee with respect to the Securities of any one or more
Series does not take office within 60 days after the retiring Trustee resigns or is removed, the retiring Trustee, the Company or the Holders of at least 10% in principal amount of the Securities of the applicable Series may petition any court of
competent jurisdiction for the appointment of a successor Trustee. 
 If the Trustee with respect to the
Securities of any one or more Series fails to comply with Section 7.10, any Securityholder who has been a bona fide Holder of a Security of the applicable Series for at least six months may petition any court of competent jurisdiction for the
removal of the Trustee and the appointment of a successor Trustee. 
 A successor Trustee shall deliver a written
acceptance of its appointment to the retiring Trustee and to the Company. Immediately after that, the retiring Trustee shall transfer all property held by it as Trustee to the successor Trustee subject to the lien provided for in Section 7.7,
the resignation or removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee with respect to each Series of Securities for which it is acting as Trustee under this
Indenture. A successor Trustee 

  
 -30-

 
shall mail a notice of its succession to each Securityholder of each such Series and, if any Bearer Securities are outstanding, publish such notice on one occasion in an Authorized Newspaper.
Notwithstanding replacement of the Trustee pursuant to this Section 7.8, the Company’s obligations under Section 7.7 hereof shall continue for the benefit of the retiring trustee with respect to expenses and liabilities incurred by it
prior to such replacement. 
 Section 7.9 Successor Trustee by Merger, etc. 

If the Trustee consolidates with, merges or converts into, or transfers all or substantially all of its corporate trust
business to, another corporation, the successor corporation without any further act shall be the successor Trustee. 
 In case at the time such successor or successors by merger, conversion or consolidation to the Trustee shall succeed to the trusts created by this Indenture any of the Securities shall have been
authenticated but not delivered; any such successor to the Trustee may adopt the certificate of authentication of any predecessor trustee, and deliver such Securities so authenticated; and in case at that time any of the Securities shall not have
been authenticated, any such successor to the Trustee may authenticate such Securities either in the name of any predecessor hereunder or in the name of the successor to the Trustee; and in all such cases such certificates shall have the full force
that it is anywhere in the Securities or in this Indenture provided that the certificate of the Trustee shall have. 
 Section
7.10 Eligibility; Disqualification. 
 This Indenture shall always have a Trustee who satisfies the
requirements of TIA Section 310(a)(1), (2) and (5). The Trustee shall always have a combined capital and surplus of at least $25,000,000 as set forth in its most recent published annual report of condition. The Trustee shall comply with
TIA Section 310(b). 
 Section 7.11 Preferential Collection of Claims Against Company. 

The Trustee is subject to TIA Section 311(a), excluding any creditor relationship listed in TIA Section 311(b).
A Trustee who has resigned or been removed shall be subject to TIA Section 311(a) to the extent indicated. 
 ARTICLE VIII.

 SATISFACTION AND DISCHARGE; DEFEASANCE 
 Section 8.1 Satisfaction and Discharge of Indenture. 
 This
Indenture shall upon Company Order cease to be of further effect (except as hereinafter provided in this Section 8.1) as it relates to all Securities of any Series, and the Trustee, at the expense of the Company, shall execute proper
instruments acknowledging satisfaction and discharge of this Indenture as it relates to all Securities of any Series, when 
 (a) either 
 (i) all Securities of such Series theretofore
authenticated and delivered (other than Securities that have been destroyed, lost or stolen and that have been replaced or paid) have been delivered to the Trustee for cancellation; or 

  
 -31-

 (ii) all such Securities not theretofore delivered to the Trustee for
cancellation 
 (1) have become due and payable, or 

(2) will become due and payable at their Stated Maturity within one year, or 

(3) are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of
notice of redemption by the Trustee in the name, and at the expense, of the Company, or 
 (4) are deemed paid
and discharged pursuant to Section 8.3, as applicable; 
 and the Company, in the case of (1), (2) or (3) above, has deposited or
caused to be deposited with the Trustee as trust funds in trust an amount sufficient for the purpose of paying and discharging the entire indebtedness on such Securities not theretofore delivered to the Trustee for cancellation, for principal and
interest to the date of such deposit (in the case of Securities which have become due and payable on or prior to the date of such deposit) or to the Stated Maturity or redemption date, as the case may be; 

(b) the Company has paid or caused to be paid all other sums payable hereunder by the Company; and 

(c) the Company has delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that
all conditions precedent herein provided for relating to the satisfaction and discharge of this Indenture have been complied with. 
 Notwithstanding the satisfaction and discharge of this Indenture, the obligations of the Company to the Trustee under Section 7.7, and, if money shall have been deposited with the Trustee pursuant to
clause (a) of this Section, the provisions of Sections 2.4, 2.7, 2.8, 8.1 8.2 and 8.5 shall survive. 
 Section 8.2
Application of Trust Funds; Indemnification. 
 (a) Subject to the provisions of Section 8.5, all
money deposited with the Trustee pursuant to Section 8.1, all money and U.S. Government Obligations or Foreign Government Obligations deposited with the Trustee pursuant to Section 8.3 or 8.4 and all money received by the Trustee in
respect of U.S. Government Obligations or Foreign Government Obligations deposited with the Trustee pursuant to Section 8.3 or 8.4, shall be held in trust and applied by it, in accordance with the provisions of the Securities and this
Indenture, to the payment, either directly or through any Paying Agent (including the Company acting as its own Paying Agent) as the Trustee may determine, to the Persons entitled thereto, of the principal and

  
 -32-

 
interest for whose payment such money has been deposited with or received by the Trustee or to make Mandatory Sinking Fund Payments or analogous payments as contemplated by Section 8.3 or
8.4. 
 (b) The Company shall pay and shall indemnify the Trustee against any tax, fee or other charge imposed on
or assessed against U.S. Government Obligations or Foreign Government Obligations deposited pursuant to Section 8.3 or 8.4 or the interest and principal received in respect of such obligations other than any payable by or on behalf of Holders.

 (c) The Trustee shall deliver or pay to the Company from time to time upon Company Request any U.S. Government
Obligations or Foreign Government Obligations or money held by it as provided in Section 8.3 or 8.4 which, in the opinion of a nationally recognized firm of independent certified public accountants expressed in a written certification thereof
delivered to the Trustee, are then in excess of the amount thereof which then would have been required to be deposited for the purpose for which such U.S. Government Obligations or Foreign Government Obligations or money were deposited or received.
This provision shall not authorize the sale by the Trustee of any U.S. Government Obligations or Foreign Government Obligations held under this Indenture. 
 Section 8.3 Legal Defeasance of Securities of any Series. 

Unless this Section 8.3 is otherwise specified pursuant to Section 2.2 to be inapplicable to Securities of any
Series, the Company shall be deemed to have paid and discharged the entire indebtedness on all the outstanding Securities of such Series on the 91st day after the date of the deposit referred to in subparagraph (d) hereof, and the provisions of
this Indenture, as it relates to such outstanding Securities of such Series, shall no longer be in effect (and the Trustee, at the expense of the Company, shall, at Company Request, execute proper instruments acknowledging the same), except as to:

 (a) the rights of Holders of Securities of such Series to receive, from the trust funds described in
subparagraph (d) hereof, (i) payment of the principal of and each installment of principal of and interest on the outstanding Securities of such Series on the Stated Maturity of such principal or installment of principal or interest and
(ii) the benefit of any Mandatory Sinking Fund Payments applicable to the Securities of such Series on the day on which such payments are due and payable in accordance with the terms of this Indenture and the Securities of such Series;

 (b) the provisions of Sections 2.4, 2.7, 2.8, 8.2, 8.3 and 8.5; 

(c) the rights, powers, trust and immunities of the Trustee hereunder; provided that the following conditions shall have
been satisfied: 
 (d) the Company shall have deposited or caused to be deposited irrevocably with the Trustee as
trust funds in trust for the purpose of making the following payments, specifically pledged as security for and dedicated solely to the benefit of the Holders of such Securities (i) in the case of Securities of such Series denominated in
Dollars, cash in Dollars (or such other money or currencies as shall then be legal tender in the United States) 

  
 -33-

 
and/or U.S. Government Obligations, or (ii) in the case of Securities of such Series denominated in a Foreign Currency (other than a composite currency), money and/or Foreign Government
Obligations, which through the payment of interest and principal in respect thereof, in accordance with their terms, will provide (and without reinvestment and assuming no tax liability will be imposed on such Trustee), not later than one day before
the due date of any payment of money, an amount in cash, sufficient, in the opinion of a nationally recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, to pay and discharge each
installment of principal (including mandatory sinking fund or analogous payments) of and interest, if any, on all the Securities of such Series on the dates such installments of interest or principal are due; 

(e) such deposit will not result in a breach or violation of, or constitute a default under, this Indenture or any other
agreement or instrument to which the Company is a party or by which it is bound; 
 (f) no Default or Event of
Default with respect to the Securities of such Series shall have occurred and be continuing on the date of such deposit or during the period ending on the 91st day after such date; 

(g) the Company shall have delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel to the effect
that (i) the Company has received from, or there has been published by, the Internal Revenue Service a ruling, or (ii) since the date of execution of this Indenture, there has been a change in the applicable Federal income tax law, in
either case to the effect that, and based thereon such Opinion of Counsel shall confirm that, the Holders of the Securities of such Series will not recognize income, gain or loss for Federal income tax purposes as a result of such deposit,
defeasance and discharge and will be subject to Federal income tax on the same amount and in the same manner and at the same times as would have been the case if such deposit, defeasance and discharge had not occurred; 

(h) the Company shall have delivered to the Trustee an Officers’ Certificate stating that the deposit was not made by
the Company with the intent of preferring the Holders of the Securities of such Series over any other creditors of the company or with the intent of defeating, hindering, delaying or defrauding any other creditors of the Company; 

(i) such deposit shall not result in the trust arising from such deposit constituting an investment company (as defined in
the Investment Company Act of 1940, as amended), or such trust shall be qualified under such Act or exempt from regulation thereunder; and 
 (j) the Company shall have delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent provided for relating to the defeasance contemplated
by this Section have been complied with. 
 Section 8.4 Covenant Defeasance. 

Unless this Section 8.4 is otherwise specified pursuant to Section 2.2 to be inapplicable to Securities of any
Series, on and after the 91st day after the date of the deposit referred to in subparagraph (a) hereof, the Company may omit to comply with any term, 

  
 -34-

 
provision or condition set forth under Sections 4.2, 4.3, 4.4, 4.6 (other than with respect to the Company) and 4.7, as well as any additional covenants contained in a supplemental indenture
hereto for a particular Series of Securities or a Board Resolution or an Officers’ Certificate delivered pursuant to Section 2.2 (and the failure to comply with any such covenants shall not constitute a Default or Event of Default under
Section 6.1) and the occurrence of any event described in clause (e) of Section 6.1 shall not constitute a Default or Event of Default hereunder, with respect to the Securities of such Series; provided that the following conditions
shall have been satisfied: 
 (a) With reference to this Section 8.4, the Company has deposited or caused to
be irrevocably deposited (except as provided in Section 8.2(c)) with the Trustee as trust funds in trust, specifically pledged as security for, and dedicated solely to, the benefit of the Holders of such Securities (i) in the case of
Securities of such Series denominated in Dollars, cash in Dollars (or such other money or currencies as shall then be legal tender in the United States) and/or U.S. Government Obligations, or (ii) in the case of Securities of such Series
denominated in a Foreign Currency (other than a composite currency), money and/or Foreign Government Obligations, which through the payment of interest and principal in respect thereof, in accordance with their terms, will provide (and without
reinvestment and assuming no tax liability will be imposed on such Trustee), not later than one day before the due date of any payment of money, an amount in cash, sufficient, in the opinion of a nationally recognized firm of independent certified
public accountants expressed in a written certification thereof delivered to the Trustee, to pay principal and interest, if any, on and any mandatory sinking fund in respect of the Securities of such Series on the dates such installments of interest
or principal are due; 
 (b) Such deposit will not result in a breach or violation of, or constitute a default
under, this Indenture or any other agreement or instrument to which the Company is a party or by which it is bound; 
 (c) No Default or Event of Default with respect to the Securities of such Series shall have occurred and be continuing on the date of such deposit or during the period ending on the 91st day after such
date; 
 (d) the Company shall have delivered to the Trustee an Opinion of Counsel confirming that Holders of the
Securities of such Series will not recognize income, gain or loss for federal income tax purposes as a result of such deposit and defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as
would have been the case if such deposit and defeasance had not occurred; 
 (e) the Company shall have delivered
to the Trustee an Officers’ Certificate stating the deposit was not made by the Company with the intent of preferring the Holders of the Securities of such Series over any other creditors of the Company or with the intent of defeating,
hindering, delaying or defrauding any other creditors of the Company; and 
 (f) The Company shall have delivered
to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that all conditions precedent herein provided for relating to the defeasance contemplated by this Section have been complied with. 

  
 -35-

 Section 8.5 Repayment to Company. 

The Trustee and the Paying Agent shall pay to the Company upon request any money held by them for the payment of principal
and interest that remains unclaimed for two years. After that, Securityholders entitled to the money must look to the Company for payment as general creditors unless an applicable abandoned property law designates another Person. 

Section 8.6 Reinstatement. 
 If the Trustee or Paying Agent is unable to apply any money or U.S. Government Obligations in accordance with Section 8.1, 8.3 or 8.4, as the case may be, by reason of any legal proceeding or by
reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Company’s obligations under this Indenture and the Securities shall be revived and reinstated as though
no deposit had occurred pursuant to Section 8.1, 8.3 or 8.4, as the case may be, until such time as the Trustee or Paying Agent is permitted to apply all such money or U.S. Government Obligations in accordance with Section 8.1, 8.3 or 8.4,
as the case may be; provided, however, that if the Company makes any payment of principal of, premium, if any, or interest on any Securities because of reinstatement of its obligations, the Company shall be subrogated to the rights of the holders of
such Securities to receive such payment from the money or U.S. Government Obligations held by the Trustee or Paying Agent. 

ARTICLE IX. 

AMENDMENTS AND WAIVERS 
 Section 9.1 Without Consent of Holders. 
 The Company and
the Trustee may amend or supplement this Indenture or the Securities of one or more Series without the consent of any Securityholder: 
 (a) to cure any ambiguity, omission, defect or inconsistency; 
 (b)
to comply with Article V; 
 (c) to provide for uncertificated Securities in addition to or in place of
certificated Securities; 
 (d) to secure the Securities or any Series; 

(e) to add to the covenants of the Company for the benefit of the Holders or to surrender any right or power herein
conferred upon the Company; 
 (f) to make any change that does not adversely affect the rights of any
Securityholder in any material respect; 
 (g) to provide for the issuance of and establish the form and terms
and conditions of Securities of any Series as permitted by this Indenture; 

  
 -36-

 (h) to evidence and provide for the acceptance of appointment hereunder by a
successor Trustee with respect to the Securities of one or more Series and to add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one
Trustee; or 
 (i) to comply with requirements of the SEC in order to effect or maintain the qualification of
this Indenture under the TIA. 
 Section 9.2 With Consent of Holders. 

The Company and the Trustee may enter into a supplemental indenture hereto with the written consent of the Holders of at
least a majority in principal amount of the outstanding Securities of each Series affected by such supplemental indenture (including consents obtained in connection with a tender offer or exchange offer for the Securities of such Series), for the
purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Indenture or of any supplemental indenture hereto or of modifying in any manner the rights of the Securityholders of each such Series. Except
as provided in Section 6.13, the Holders of at least a majority in principal amount of the outstanding Securities of each Series affected by such waiver by notice to the Trustee (including consents obtained in connection with a tender offer or
exchange offer for the Securities of such Series) may waive compliance by the Company with any provision of this Indenture or the Securities with respect to such Series. 

It shall not be necessary for the consent of the Holders of Securities under this Section 9.2 to approve the
particular form of any proposed supplemental indenture hereto or waiver, but it shall be sufficient if such consent approves the substance thereof. After a supplemental indenture hereto or waiver under this Section becomes effective, the Company
shall mail to the Holders of Securities affected thereby and, if any Bearer Securities affected thereby are outstanding, publish on one occasion in an Authorized Newspaper, a notice briefly describing the supplemental indenture or waiver. Any
failure by the Company to mail or publish such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such supplemental indenture or waiver. 

Section 9.3 Limitations. 
 Without the consent of each Securityholder affected, an amendment or waiver may not: 
 (a) change the amount of Securities whose Holders must consent to an amendment, supplement or waiver; 
 (b) reduce the rate of or extend the time for payment of interest (including default interest) on any Security; 
 (c) reduce the principal or change the Stated Maturity of any Security or reduce the amount of, or postpone the date fixed for, the payment of any sinking fund or analogous obligation; 

  
 -37-

 (d) reduce the principal amount of a Security issued with original issue
discount or any other Security payable upon acceleration of the maturity thereof; 
 (e) waive a Default or Event
of Default in the payment of the principal of or interest, if any, on any Security (except a rescission of acceleration of the Securities of any Series by the Holders of at least a majority in principal amount of the outstanding Securities of such
Series and a waiver of the payment default that resulted from such acceleration); 
 (f) make the principal of or
interest, if any, on any Security payable in any currency other than that stated in the Security; 
 (g) make any
change in Section 6.8, 6.13, 9.3 (this sentence), 10.15 or 10.16; 
 (h) waive a redemption payment with
respect to any Security or change any of the provisions with respect to the redemption of any Securities; 
 (i)
make any change with respect to the ranking of any Securities relative to any other Debt or other obligation of the Company; 
 (j) release any security interest that may have been granted in favor of the Securityholder; or 
 (k) make any change in a Securityholder’s ability to convert or exchange Securities in any material respect. 
 Section 9.4 Compliance with Trust Indenture Act. 
 Every
amendment to this Indenture or the Securities of one or more Series shall be set forth in a supplemental indenture hereto that complies with the TIA as then in effect. 
 Section 9.5 Revocation and Effect of Consents. 
 Until an
amendment or waiver becomes effective, a consent to it by a Holder of a Security is a continuing consent by the Holder and every subsequent Holder of a Security or portion of a Security that evidences the same Debt as the consenting Holder’s
Security, even if notation of the consent is not made on any Security. However, any such Holder or subsequent 

Holder may revoke the consent as to his Security or portion of a Security if the Trustee receives the notice of revocation
before the date the amendment or waiver becomes effective. 
 Any amendment or waiver once effective shall bind
every Securityholder of each Series affected by such amendment or waiver unless it is of the type described in any of clauses (a) through (k) of Section 9.3. In that case, the amendment or waiver shall bind each Holder of a Security
who has consented to it and every subsequent Holder of a Security or portion of a Security that evidences the same Debt as the consenting Holder’s Security. 

  
 -38-

 The Company may, but shall not be obligated to, fix a record date for the
purpose of determining the Securityholders entitled to give their consent or take any other action described above or required or permitted to be taken pursuant to this Indenture. If a record date is fixed, then notwithstanding the immediately
preceding paragraph, those Persons who were Securityholders at such record date (or their duly assigned proxies), and only those Persons, shall be entitled to give such consent or to revoke any consent previously given or to take any such action,
whether or not such Persons continue to be Holders after such record date. 
 Section 9.6 Notation on or Exchange of
Securities. 
 If an amendment changes the terms of any Security of any Series, the Trustee may require the
Holder of the Security to deliver such Security to the Trustee. The Trustee may place an appropriate notation on the Security regarding the changed terms and return such Security to the Holder. Alternatively, the Company in exchange for Securities
of any Series may issue and the Trustee shall authenticate upon request new Securities of that Series that reflect the amendment or waiver. 
 Section 9.7 Trustee Protected. 
 In executing, or accepting
the additional trusts created by, any supplemental indenture hereto permitted by this Article or the modifications thereby of the trusts created by this Indenture, the Trustee shall be entitled to receive, and (subject to Section 7.1) shall be
fully protected in relying upon, an Opinion of Counsel stating that the execution of such supplemental indenture is authorized or permitted by this Indenture. The Trustee shall sign all supplemental indentures hereto, except that the Trustee need
not sign any supplemental indenture hereto that adversely affects its rights. 
 Section 9.8 Payment for Consent.

 Neither the Company nor any Affiliate of the Company shall, directly or indirectly, pay or cause to be paid
any consideration, whether by way of interest, fee or otherwise, to any Holder for or as an inducement to any consent, waiver or amendment of any of the terms or provisions of this Indenture applicable to the Securities of any Series or the
Securities of any Series unless such consideration is offered to be paid to all Holders of the Securities of such Series that so consent, waive or agree to amend in the time frame set forth in solicitation documents relating to such consent.

 ARTICLE X. 
 MISCELLANEOUS 
 Section 10.1 Trust Indenture Act Controls. 

If any provision of this Indenture limits, qualifies, or conflicts with another provision which is required or deemed to
be included in this Indenture by the TIA, such required or deemed provision shall control. 

  
 -39-

 Section 10.2 Notices. 

Any notice or communication by the Company or the Trustee to the other is duly given if in writing and delivered in person
or mailed by first-class mail: 
 if to the Company: 

Rainmaker Systems, Inc. 
 900 East Hamilton Avenue, Suite 400 
 Campbell, California 95008

 Attention: Chief Financial Officer 

if to the Trustee: 
  

									
		 	[	 	]	 		  	
		 	[	 	]	 		  	
		 	[	 	]	 		  	
		 	Attention: [	 	]	 		  	

 The Company or the Trustee by notice to the other may designate additional or
different addresses for subsequent notices or communications. 
 Any notice or communication to a Securityholder
shall be mailed by first-class mail to his address shown on the register kept by the Registrar and, if any Bearer Securities are outstanding, published in an Authorized Newspaper. Failure to mail a notice or communication to a Securityholder of any
Series or any defect in it shall not affect its sufficiency with respect to other Securityholders of that or any other Series. 
 If a notice or communication is mailed or published in the manner provided above, within the time prescribed, it is duly given, whether or not the Securityholder receives it. 

If the Company mails a notice or communication to Securityholders, it shall mail a copy to the Trustee and each Agent at
the same time. 
 Section 10.3 Communication by Holders with Other Holders. 

Securityholders of any Series may communicate pursuant to TIA Section 312(b) with other Securityholders of that
Series or any other Series with respect to their rights under this Indenture or the Securities of that Series or all Series. The Company, the Trustee, the Registrar and anyone else shall have the protection of TIA Section 312(c). 

  
 -40-

 Section 10.4 Certificate and Opinion as to Conditions Precedent. 

Upon any request or application by the Company to the Trustee to take any action under this Indenture, the Company shall
furnish to the Trustee: 
 (a) an Officers’ Certificate stating that, in the opinion of the signers, all
conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied with; and 
 (b) an Opinion of Counsel stating that, in the opinion of such counsel, all such conditions precedent have been complied with. 
 Section 10.5 Statements Required in Certificate or Opinion. 

Each certificate or opinion with respect to compliance with a condition or covenant provided for in this Indenture (other
than a certificate provided pursuant to TIA Section 314(a)(4)) shall comply with the provisions of TIA Section 314(e) and shall include: 
 (a) a statement that the Person making such certificate or opinion has read such covenant or condition; 
 (b) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based; 

(c) a statement that, in the opinion of such Person, he has made such examination or investigation as is necessary to
enable him to express an informed opinion as to whether or not such covenant or condition has been complied with; and 
 (d) a statement as to whether or not, in the opinion of such Person, such condition or covenant has been complied with. 
 Section 10.6 Rules by Trustee and Agents. 
 The Trustee may
make reasonable rules for action by or a meeting of Securityholders of one or more Series. Any Agent may make reasonable rules and set reasonable requirements for its functions. 

Section 10.7 Legal Holidays. 
 Unless otherwise provided by Board Resolution, supplemental indenture hereto or Officers’ Certificate for a particular Series, a “LEGAL HOLIDAY” is any day that is not a Business Day. If a
payment date is a Legal Holiday at a place of payment, payment may be made at that place on the next succeeding day that is not a Legal Holiday, and no interest shall accrue for the intervening period. 

Section 10.8 No Recourse Against Others. 
 A director, officer, employee or stockholder, as such, of the Company shall not have any liability for any obligations of the Company under the Securities or the Indenture or for any claim based on, in
respect of or by reason of such obligations or their creation. Each Securityholder by accepting a Security waives and releases all such liability. The waiver and release are part of the consideration for the issue of the Securities. 

  
 -41-

 Section 10.9 Counterparts. 

This Indenture may be executed in any number of counterparts and by the parties hereto in separate counterparts, each of
which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. 
 Section 10.10 Governing Laws. 
 THIS INDENTURE AND THE
SECURITIES SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED IN SUCH STATE, WITHOUT REGARD TO THE CONFLICT OF LAWS PROVISIONS THEREOF. 

Section 10.11 No Adverse Interpretation of Other Agreements. 

This Indenture may not be used to interpret another indenture, loan or Debt agreement of the Company or a Subsidiary. Any
such indenture, loan or Debt agreement may not be used to interpret this Indenture. 
 Section 10.12 Successors.

 All agreements of the Company in this Indenture and the Securities shall bind its successor. All agreements of
the Trustee in this Indenture shall bind its successor. 
 Section 10.13 Severability. 

In case any provision in this Indenture or in the Securities shall be invalid, illegal or unenforceable, the validity,
legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
 Section 10.14
Table of Contents, Headings, Etc. 
 The Table of Contents, Cross Reference Table, and headings of the
Articles and Sections of this Indenture have been inserted for convenience of reference only, are not to be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof. 

Section 10.15 Securities in a Foreign Currency or in ECU. 

Unless otherwise specified in a Board Resolution, a supplemental indenture hereto or an Officers’ Certificate
delivered pursuant to Section 2.2 with respect to a particular Series of Securities, whenever for purposes of this Indenture any action may be taken by the Holders of a specified percentage in aggregate principal amount of Securities of all
Series or all Series affected by a particular action at the time outstanding and, at such time, there are outstanding Securities of any Series which are denominated in a coin or currency other than Dollars (including ECUs), then the principal amount
of Securities of such Series which shall be deemed to be outstanding for the purpose of taking such action shall be that amount of Dollars that could be obtained for such amount at the Market Exchange Rate at such time. For purposes

  
 -42-

 
of this Section 10.15, “MARKET EXCHANGE RATE” shall mean the noon Dollar buying rate in New York City for cable transfers of that currency as published by the Federal Reserve Bank
of New York; provided, however, in the case of ECUs, Market Exchange Rate shall mean the rate of exchange determined by the Commission of the European Union (or any successor thereto) as published in the Official Journal of the European Union (such
publication or any successor publication, the “JOURNAL”). If such Market Exchange Rate is not available for any reason with respect to such currency, the Trustee shall use, in its sole discretion and without liability on its part, such
quotation of the Federal Reserve Bank of New York or, in the case of ECUs, the rate of exchange as published in the Journal, as of the most recent available date, or quotations or, in the case of ECUs, rates of exchange from one or more major banks
in The City of New York or in the country of issue of the currency in question or, in the case of ECUs, in Luxembourg or such other quotations or, in the case of ECUs, rates of exchange as the Trustee, upon consultation with the Company, shall deem
appropriate. The provisions of this paragraph shall apply in determining the equivalent principal amount in respect of Securities of a Series denominated in currency other than Dollars in connection with any action taken by Holders of Securities
pursuant to the terms of this Indenture. 
 All decisions and determinations of the Trustee regarding the Market
Exchange Rate or any alternative determination provided for in the preceding paragraph shall be in its sole discretion and shall, in the absence of manifest error, be conclusive to the extent permitted by law for all purposes and irrevocably binding
upon the Company and all Holders. 
 Section 10.16 Judgment Currency. 

The Company agrees, to the fullest extent that it may effectively do so under applicable law, that (a) if for the
purpose of obtaining judgment in any court it is necessary to convert the sum due in respect of the principal of or interest or other amount on the Securities of any Series (the “REQUIRED CURRENCY”) into a currency in which a judgment will
be rendered (the “JUDGMENT CURRENCY”), the rate of exchange used shall be the rate at which in accordance with normal banking procedures the Trustee could purchase in The City of New York the Required Currency with the Judgment Currency on
the day on which final unappealable judgment is entered, unless such day is not a New York Banking Day, then, the rate of exchange used shall be the rate at which in accordance with normal banking procedures the Trustee could purchase in The City of
New York the Required Currency with the Judgment Currency on the New York Banking Day preceding the day on which final unappealable judgment is entered and (b) its obligations under this Indenture to make payments in the Required Currency
(i) shall not be discharged or satisfied by any tender, any recovery pursuant to any judgment (whether or not entered in accordance with Subsection (a)), in any currency other than the Required Currency, except to the extent that such tender or
recovery shall result in the actual receipt, by the payee, of the full amount of the Required Currency expressed to be payable in respect of such payments, (ii) shall be enforceable as an alternative or additional cause of action for the
purpose of recovering in the Required Currency the amount, if any, by which such actual receipt shall fall short of the full amount of the Required Currency so expressed to be payable, and (iii) shall not be affected by judgment being obtained
for any other sum due under this Indenture. For purposes of the foregoing, “NEW YORK BANKING DAY” means any day except a Saturday, Sunday or a legal holiday in The City of New York on which banking institutions are authorized or required
by law, regulation or executive order to close. 

  
 -43-

 ARTICLE XI. 
 SINKING FUNDS 
 Section 11.1 Applicability of Article. 

The provisions of this Article shall be applicable to any sinking fund for the retirement of the Securities of a Series,
except as otherwise permitted or required by any form of Security of such Series issued pursuant to this Indenture. 
 The minimum amount of any sinking fund payment provided for by the terms of the Securities of any Series is herein referred to as a “MANDATORY SINKING FUND PAYMENT” and any other amount provided
for by the terms of Securities of such Series is herein referred to as an “OPTIONAL SINKING FUND PAYMENT.” If provided for by the terms of Securities of any Series, the cash amount of any sinking fund payment may be subject to reduction as
provided in Section 11.2. Each sinking fund payment shall be applied to the redemption of Securities of any Series as provided for by the terms of the Securities of such Series. 

Section 11.2 Satisfaction of Sinking Fund Payments with Securities. 

The Company may, in satisfaction of all or any part of any sinking fund payment with respect to the Securities of any
Series to be made pursuant to the terms of such Securities (1) deliver outstanding Securities of such Series to which such sinking fund payment is applicable (other than any of such Securities previously called for mandatory sinking fund
redemption) and (2) apply as credit Securities of such Series to which such sinking fund payment is applicable and which have been redeemed either at the election of the Company pursuant to the terms of such Series of Securities (except
pursuant to any mandatory sinking fund) or through the application of permitted Optional Sinking Fund Payments or other optional redemptions pursuant to the terms of such Securities; provided that such Securities have not been previously so
credited. Such Securities shall be received by the Trustee, together with an Officers’ Certificate with respect thereto, not later than 15 days prior to the date on which the Trustee begins the process of selecting Securities for redemption,
and shall be credited for such purpose by the Trustee at the price specified in such Securities for redemption through operation of the sinking fund and the amount of such sinking fund payment shall be reduced accordingly. If as a result of the
delivery or credit of Securities in lieu of cash payments pursuant to this Section 11.2, the principal amount of Securities of such Series to be redeemed in order to exhaust the aforesaid cash payment shall be less than $100,000, the Trustee
need not call Securities of such Series for redemption, except upon receipt of a Company Order that such action be taken, and such cash payment shall be held by the Trustee or a Paying Agent and applied to the next succeeding sinking fund payment;
provided, however, that the Trustee or such Paying Agent shall from time to time upon receipt of a Company Order pay over and deliver to the Company any cash payment so being held by the Trustee or such Paying Agent upon delivery by the Company to
the Trustee of Securities of that Series purchased by the Company having an unpaid principal amount equal to the cash payment required to be released to the Company. 

  
 -44-

 Section 11.3 Redemption of Securities for Sinking Fund. 

Not less than 45 days (unless otherwise indicated in the Board Resolution, supplemental indenture hereto or Officers’
Certificate in respect of a particular Series of Securities) prior to each sinking fund payment date for any Series of Securities, the Company will deliver to the Trustee an Officers’ Certificate specifying the amount of the next ensuing
Mandatory Sinking Fund Payment for that Series pursuant to the terms of that Series, the portion thereof, if any, which is to be satisfied by payment of cash and the portion thereof, if any, which is to be satisfied by delivering and crediting of
Securities of that Series pursuant to Section 11.2, and the optional amount, if any, to be added in cash to the next ensuing Mandatory Sinking Fund Payment, and the Company shall thereupon be obligated to pay the amount therein specified. Not
less than 30 days (unless otherwise indicated in the Board Resolution, supplemental indenture hereto or Officers’ Certificate in respect of a particular Series of Securities) before each such sinking fund payment date the Trustee shall select
the Securities to be redeemed upon such sinking fund payment date in the manner specified in Section 3.2 and cause notice of the redemption thereof to be given in the name of and at the expense of the Company in the manner provided in
Section 3.3. Such notice having been duly given, the redemption of such Securities shall be made upon the terms and in the manner stated in Sections 3.4, 3.5 and 3.6. 

  
 -45-

 IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed as of
the day and year first above written. 
  

			
	THE COMPANY:
	RAINMAKER SYSTEMS, INC.
		
	By:	 	 
		 	Name:
		 	Its:
	THE TRUSTEE:
	[                            
                                        
]
		
	By:	 	 
		 	Name:
		 	Its:

  
 -46-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00183-of-00352.parquet"}]]